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1SUMMARY
The work described in this thesis is concerned with the 
lipids present in the fatty plaques which develop in human 
arteries during the processes of atherosclerotic degeneration.
The variations in concentration and composition of the major 
lipid classes as the disease progresses have received previous 
attention. However, other lipids present in smaller quantities 
have not been investigated in detail, A study of such 
constituents was undertaken since it seemed possible that seme 
of them might be of significance in the pathology of athero­
sclerosis.
Early attempts to identify the minor steroids which accompany 
cholesterol in atherosclerotic lesions were hindered, and to some 
extent vitiated, by the lack of suitable microanalytical 
techniques. Since accumulation of adequate quantities of lipid 
necessitated collection and pooling of a large number of arteries, 
sometimes over a period of years, it is possible that many of 
the compounds identified were artefacts of the original steroids.
In the present study the use of thin-layer chromatography (TLC), 
gas-liquid chromatograply (GLC) and combined GLC-mass spectrometry 
(GC-MS) has facilitated rapid and accurate analyses of minor 
lipids from individual arteries.
Lesions from single human aortas, obtained within 24 hours 
after death, were classified according to the W,H,0. convention. 
Following extraction, the lipids were fractionated by column 
chromatography. The extraction and chromatographic procedures 
were performed expeditiously to minimise artefact formation.
By repeated TLC on modified layers 5°f-cholestan-3^-ol 
(cholestanol) was isolated from both sterol and sterol ester 
fractions. The concentration of this compound in severely 
diseased tissue was estimated by GLC, and found to be considerably
less than had been reported by some earlier workers. Since 
recent publications suggest that the aortal concentration of 
cholestanol does not differ markedly from those of other tissues, 
and no relationship appears to exist between its aortal content 
and degree of atherosclerosis, it seems unlikely that this 
compound plays any significant role in the development of the 
disease,
26-Hydro xycholesterol is known to occur in both normal and 
diseased aortas. Although its function is unknown, the increased 
concentrations found in lesions suggest a possible relationship 
between this sterol and atherosclerosis. The present work 
demonstrates the occurrence in both early and advanced lesions 
of a diesterified form of this sterol. The distribution of the 
fatty acids of this unique type of ester is markedly different 
from that of the cholesterol esters. Whereas arterial 
cholesterol esters appear to be derived mainly from blood, the 
distinctive fatty acids of 26-hydroxy cholesterol diesters may 
reflect a different origin for these constituents.
Previous work in Glasgow had demonstrated the presence in 
extracts of severely diseased aortas of a group of esters 
consisting largely of cholesterol esterified with 9- and 13- 
hydroxyoctadecadienoic acids, A survey was undertaken in an 
attempt to relate the quantities of these bydroxy-esters with the 
severity of atherosclerosis. The quantities of the hydroxy-acids 
derived from these esters were determined by GLC. None of the 
bydroxy-esters were detected in the earliest lesions, but considerable 
amounts were isolated from those representing more advanced 
atherosclerosis. These results establish what may be an 
important distinction between early and advanced lesions.
In order to assist the identification of other oxygenated 
sterol esters in diseased tissue, a study was made of the oxidation
products of cholesteryl linoleate. Those derived from hydro­
peroxides produced by autoxidation and photo-oxygenation of 
cholesteryl linoleate were dissimilar, as expected from published 
data on other linoleic acid derivatives. The development of 
improved techniques enabled the identification in arterial 
extracts of bydroperoxy- and keto-esters similar to those derived 
from autoxidised cholesteryl linoleate.
It seems probable that the keto- and bydroxy-esters found 
in tissue are derived from the corresponding hydroperoxides.
The pathogenic character of lipid hydroperoxides is well established, 
and the production of bydroxy compounds has been shown to be a 
possible route for "detoxification”. The present findings may 
reflect such a process. However, the full significance of 
oxygenated derivatives of cholesteryl linoleate to the patho­
genesis of atherosclerosis requires to be ascertained. In 
particular, the origin of the hydroperoxides must be clearly 
established. At present it is not known whether these substances 
occur in arteries prior to death, or accumulate in the interval 
between death and analysis. Examination of tissues obtained 
during surgery may resolve this problem.
The metabolic processes whereby hydroperoxides arise and are 
removed are being studied in homogenates of human and animal aortas, 
and a method for the qualitative assessment of hydroperoxide 
toxicity in vivo is being developed. Whether these compounds 
arise by an enzymic or non-stereospecific oxidation should be 
determinable by resolution of the enantiomeric hydroperoxide 
derivatives.
Section f INTRODUCTI(M
COUNTRY % Total Deaths Attributable 
to Coronary Atherosclerosis
UNITED STATES 33
CANADA 32
SCOTLAND 30
AUSTRALIA 30
NEW ZEALAND 28
NORTHERN IRELAND 28
ENGLAND & WALES 27
W. GERMANY 18
TABLE 1. Proportion of deaths in 1966 attributable to
coronary atherosclerosis in countries where the 
disease is most prevalent.
51.1. THE DISEASE ATHEROSCLEROSIS
1.1.1. Introduction
-I
The World Health Organisation (WHO) defines atherosclerosis 
as "a variable combination of changes of the intima of arteries 
consisting of the focal accumulation of lipids, complex carbo­
hydrates, blood and blood products, fibrous tissue and calcified 
deposits, and associated with medial changes”.
The lethal sequelae of atherosclerosis, coronaxy heart 
disease and cerebral vascular accident claim more victims in 
the United States than any other cause of death, one-third of 
all deaths being attributable to coronary atherosclerosis in 
1966 , The death rate due to this cause in Europe is only 
slightly lower ^ (Table 1).
Atherosclerosis involves the gradual thickening of the
aortal intima by lipid deposits and fibrous tissue. The earliest
1 3recognisable manifestation of the disease is the fatty streak,9
a small superficial lesion containing lipid-filled foam cells.
Prom this the lesion is presumed to develop into a fibrous plaque
1
or a complicated lesion. Finally, rupture of the endothelial 
lining of some atheromatous plaques may result in thrombosis^.
This may completely occlude a small vessel such as a coronary 
artery causing myocardial infarction or death.
1.1. 2. The Processes of Atherogenesis
It is currently postulated that the initial event in the 
process of atherogenesis involves injury to the arterial intima 
followed by the accumulation of lipid in the vessel wall. 
Presumably vascular injury renders the intima more susceptible 
to permeation ty lipid-containing blood constituents. Such 
injuries can be induced experimentally by application of heat^
26,28
or cold to the artery wall, by mechanical injury, by radiation,
27and by the use of chemical and immunological agents.
g
Shimamoto has demonstrated, by use of electron microscopy, that 
the endothelial cells of human and rabbit aorta are equipped with 
intercellular bridges, which seem to control the size of clefts 
in the endothelial surface. When animals were treated with 
cholesterol (orally) or epinephrine (intravenous injection), 
these intercellular bridges were observed to swell and elongate.
The sizes of the clefts were increased, rendering the endothelium 
more permeable to lipid infiltration, and possibly more 
susceptible to focal development of atherosclerosis.
Several theories have been proposed to explain the process 
of lipid accumulation. The principal features of the most 
feasible current hypotheses areas follows.
The Lipid Infiltration Theory 
The lipid infiltration theory states that plaques evolve 
as a result of a reaction of the arterial wall against lipids 
which invade it from blood plasma. Most of the lipid in
5
plaques is thought to originate from lipoprotein filtration,
6possibly through clefts between the endothelial cells of the 
intima, and evidence has recently been obtained which suggests 
that a basic cause of lipid deposition may be failure of the 
arterial wall to metabolise lipids transported as lipoprotein.^
The initial fatty streaks are confined to the intima, the lipid
 ^ . 101.102. being present as large intracellular droplets.
The Thrambogenic Theory
The thrombogenic theory states that atherosclerosis results
8 9 10
from the initial formation of an intraluminal thrombus * 9
which attaches to the arterial wall and is overgrown by endothelial
7cells. Capillaries sprout from the newly grown overlying
10endothelium, providing a direct "blood supply from the lumen.
The lipid in a lesion developing in this manner is likely to
10originate from platelets, and it has been shown that foam cells 
characteristic of those in atherosclerotic plaques can be
11derived from monocytes which have phagocytosed platelets.
Lipid deposits may also arise by repeated capillary haemorrhages
12 13invading the thrombus from the lumen or adventitia, *
Lipid synthesis in the artery wall 
Although it is generally conceded that the greater 
proportion of lipid present in atherosclerotic lesions arises 
by deposition from blood, there is considerable evidence to
suggest that the arterial wall has a certain capacity to synthesise
1 h. 1 R
lipids. It has been demonstrated that human and rabbit
arterial tissues synthesise phospholipids and triglycerides, and 
16Chobanian has shown that human arterial segments obtained at
post-mortem examination are capable of synthesising all the
major lipid classes commonly found in lesions. The rate of lipid
biosynthesis is considerably greater in fatty streaks than in 
16normal intima. The major lipid classes produced are phospho­
lipids and triglycerides, but synthesis of significant quantities
17of sterols and sterol esters has also been observed.
Local factors in plaque development
Other factors may determine the site of development of an
atherosclerotic lesion. These factors may involve metabolic
changes, or degeneration of parts of the artery wall due to ageing 
18 19or other causes, 9 It has been suggested that the localis­
ation of coronary atherosclerotic plaques may be explained in 
terms of the variation of haemodynamic stresses within the blood 
vessel. Plaques are observed to develop predominantly at sites
820 21of arterial narrowing and bifurcation, * i.e. at positions 
experiencing greater hydrostatic pressures. It has also been
22'
demonstrated that thrombi develop preferentially at these sites, 
possibly indicating that such stresses may cause vessel injury 
resulting in platelet aggregation and subsequent development 
of thrombi.
It therefore appears that arterial accumulation of lipid 
and plaque development are caused by a number of factors. At 
the present time the infiltration mechanism is the most favoured. 
Although thrombus formation and subsequent incorporation into 
the arterial intima may account for the formation of some 
arterial lesions, it is probably too rare an event to account 
for the extensive atherosclerosis frequently observed in grossly 
diseased aortas. Local lipid synthesis is a minor factor in 
arterial lipid accumulation. The greater part of the lipid 
present in plaques originates from blood.
91.1.3. Epidemiology of atherosclerosis
Life style is apparently a very important factor in the
development of atherosclerosis. Although the disease is
universal, it is most prevalent amongst people of the affluent
29
and technologically advanced countries. It is particularly
interesting that populations which migrate from a country with
a low incidence of the disease (e.g. Japan) to one where the
disease is a major cause of death (e.g. United States) tend to
have a much higher death rate attributable to atherosclerosis
than those remaining in their native land.^*^ Keys and co- 
30 32 33
workers 9 9 have demonstrated a relationship between death
rate from coronary heart disease, the mean serum cholesterol
level and the proportion of calories derived from total dietary
fat. Further striking evidence indicating a relationship
between dietary fat and coronary heart disease was noted during
the 1939-4-5 war, where, in many European countries, there was a
sharp drop in the death rate from circulatory diseases. This
34-was accompanied by a fall in consumption of animal fat. Thus
high fat consumption and the associated high serum cholesterol 
levels can almost certainly be implicated in the development of 
atherosclerosis, the high level of fat consumed in the more 
affluent countries being reflected in the geographical distribution 
of the disease*
Positive correlations have also been obtained between coronary
35 3^,37heart disease and lack of exercise , cigarette smoking ,
38 39—4-ihypertension, stress' and the mineral content of drinking water.
It has been suggested that deficiency in the dietary intake of
I rt
linoleic acid may pertain to atheromata formation. The increase 
in atherosclerosis in Britain is roughly paralleled by a decrease 
in linoleic acid consumption due to hydrogenation of vegetable
10
oils and eating of prepared foods* Linoleate deficiency
increases the proportion of cholesterol esterified with fatty
acids synthesised by the body^ (e.g. oleate, palmitate, stearate),
and it has been suggested that such esters msy be preferentially
deposited in tissues. Though this idea is difficult to reconcile
with the fact that the predominant cholesterol ester in advanced
arterial lesions is linoleate, it has been shown that the
incorporation of polyunsaturated fatty acids in diets reduces
L2
the level of blood cholesterol. This may possibly be due
to more rapid catabolism of cholesterol when esterified with
4.3
polyunsaturated acids. ^
l.l.k. Cholesterol and Atherosclerosis
There is fairly general agreement that elevated blood 
cholesterol levels contribute significantly to the genesis and/
if J|
or progression of atherosclerosis in man. It is not clear, 
however, whether the excess cholesterol in plasma is absorbed 
from the diet or is synthesised by the body tissues. Although 
most tissues are capable of synthesising cholesterol, only in
the liver, skin and intestine is there a high rate of cholestero-
k5 k&M A8-50genesis. Experiments using dogs and rats have
demonstrated that a high dietary intake of cholesterol results
in a striking suppression of body cholesterol synthesis. Since
the bulk of cholesterol synthesis in these animals occurs in the 
51 52liver, * * there is apparently a control mechanism whereby
a high dietary intake of cholesterol suppresses hepatic synthesis. 
The extrahepatic tissues lack such a feedback system and 
consequently synthesise cholesterol even when the animals are on 
high cholesterol diets^’^ .
Studies on human subjects have shown that a high dietary 
intake of cholesterol does not suppress synthesis to nearly the
11
53-57 82same extent as in animals, 9 This indicates that either
the human liver is not so susceptible to the type of control
mechanism found in dogs and rats, or that a larger proportion
of endogenous cholesterol is produced in tissues other than the
liver, which are not affected by a feedback mechanism. Since
56 58
in vitro studies have shown that human liver 9 is regulated
in the same way as other species the latter possibility would
appear the more likely.
The major catabolic pathway of cholesterol is by conversion
to bile acids, and many studies have been made in attempts to
relate excretion rates with serum cholesterol levels. When 
50 47rats and dogs are fed a high cholesterol diet they are able
to compensate for increased cholesterol absorption by increases
in faecal bile acid output. Humans are unable to compensate in 
54,59,60.
this way. However, faecal bile acid output in man can
61—63
be enhanced by feeding of polyunsaturated fatty acids. The
increase in cholesterol catabolism is paralleled by a reduction
Sh.in serum cholesterol levels. * Boyd has studied the
effect of both a high linoleate diet and orally administered
etlynyl estradiol on cholesterol metabolism. Linoleate was
found to reduce the quantities of plasma cholesterol in humans.
The effect was accompanied Ty an increase in the proportions of
cholesteryl linoleate in plasma relative to cholesteryl palmitate
and oleate. The effect of estrogen was to reduce the relative
proportion of linoleate ester from about k5% of the total
6 5cholesterol esters to It has been suggested that poly­
unsaturated cholesterol esters are more rapidly metabolised than
43the saturated esters. The decrease in serum cholesterol levels
when linoleate is added to the diet may reflect a greater catabolic
rate of cholesterol due to an increase in the proportion of the
6 5more readily metabolised cholesteryl linoleate. The effect of
12
estrogen may be to increase the rate of catabolism, and since
cholesteryl linoleate is preferentially catabolised, its reduction
in plasma might be expected. The wide fluctuation of serum
66 335
cholesterol levels of woman throughout the menstrual cycle, * 
during pregnancy and after menopause may be rationalised on 
the basis of estrogen production.
Some substantiation for Boyd*s proposals was provided by his 
discovery in human serum of a fatty acid esterified form of 7*- 
hydroxycholesterol. It seems possible that such esters may be 
intermediates in the catabolism of cholesterol to bile acids* If 
hydroxylation at on the cholesterol nucleus is an early step
in the formation of bile acids, then this may be facilitated by 
the presence of polyunsaturated fatty acids esterified at ^(3)*
It has been demonstrated that the relative rate of 7-hydroxylation 
of cholesterol esters by autoxidation increases with the degree of
69
unsaturation of the acyl moiety. The mechanism of such an
65,69autoxidation is believed to proceed by initial formation of
a hydroperoxy function on the fatty acid moiety, and an intramolecular
rearrangement in which the sterol nucleus is hydroxylated at £(7)
by cleavage of an internal peroxide. This attractive hypothesis
that cholesterol may be catabolised as its linoleate ester has
been challenged as a result of more recent studies. Ogura and
Yamasaki,^ having performed in vitro and in vivo studies on the
metabolism of 7^-hydroxychole sterol and its esters in rats,
conclude that esters of cholesterol and of T^-hydroxycholesterol
70 71are reserve, but not activated catabolic materials. 9
Human blood plasma, contains a larger proportion of esterified 
cholesterol than any other tissue. Cholesterol esters appear to 
be a preferred form for cholesterol storage since an increase in 
hepatic storage is reflected by an increase in the ratio of
56the esterified to free form, and the large proportions found in 
plasma probably reflect an important role in cholesterol transport 
mechanisms throughout the body. The high proportion of 
cholesteryl linoleate in plasma (about k-Ofo of total cholesterol 
esters) is striking when contrasted with human liver where a much 
higher proportion of saturated esters is found. It is thought that
56
in humans the bulk of cholesterol ester is synthesised in plasma"^  
by means of the lecithin-cholesterol-acyl transferase (LCAT) enzyme
73discovered by G-lomset and co-workers. This enzyme leads to a
7^f* 7 5preferential formation of cholesteryl linoleate 9 and probably 
accounts for the preponderance of this ester in plasma, LCAT may 
also be involved in the transfer of cholesterol synthesised or 
deposited in extrahepatic tissues to the liver where catabolism
takes place.56,76,329 
77Macdonald has studied the effect of diet on the variations 
of serum lipid levels. Healthy young men were subjected to diets 
consisting of a mixture of fat and carbohydrate. The fats used 
were either cream (highly saturated), or sunflower oil (polyunsaturated 
and were augmented with either glucose or sucrose. Sunflower oils 
caused the total cholesterol level to fall, in accord with previous 
findings. In the sunflower oil diet supplemented with sucrose, the 
fall in total cholesterol was brought about by a decrease in free 
cholesterol, whereas glucose reduced the serum cholesterol ester 
levels. Yfhen cream was fed with either sucrose or glucose the total 
cholesterol level remained unchanged. However, the glucose/cream 
diet appeared to reduce the quantity of free cholesterol in serum. 
Previous conflicting reports regarding the role of dietary carbo-
70 7q
hydrates, 9 can probably be explained by failure to appreciate 
that the metabolism of free and esterified cholesterol are affected 
differently,
Macdonald has also shown that dietary sucrose is related to
1L.
an increase in serum glyceride levels, a condition associated with 
an increased incidence of coronary thrombosis. Since there is also 
close association of high serum cholesterol levels with athero­
sclerosis, correlations of this kind may be of considerable 
importance in the dietary control of coronary heart disease.
On Op
Ho and Taylor 9 have suggested a very plausible hypothesis 
relating the development of atherosclerosis to serum cholesterol 
levels. They showed that when blood cholesterol levels are 
increased by feeding a high cholesterol diet to animals, cholesterol 
deposits in all tissues, without any predisposing factors such as 
hypertension or tissue injuiy, By subsequent feeding of poly­
unsaturated fat, the cholesterol levels in almost all tissues could 
be reduced to normal after a fairly short period of time. The 
removal of cholesterol from the aorta however was very much slower.
It appears possible, nevertheless, that the process of athero­
sclerosis is at least partially reversible and that the progression 
of such cholesterol induced atherosclerosis can be halted.
It is likely that when plasma cholesterol levels attain a 
critical level, cholesterol is deposited into all tissues, particularly 
the arteries. When blood cholesterol levels return to normal, 
the excessive cholesterol in most tissues returns to the plasma 
and is excreted by the liver. Since cholesterol in the aorta has 
a much lower rate of return to the plasma, a considerable excess 
still remains after reduction of the plasma cholesterol levels to 
normal. Subsequent influxes bring more cholesterol into the 
aorta before the vessel is able to clear out that already deposited. 
Thus progressively more lipid accumulates* Tissue reactions then 
ensue and typical atheromatous plaques follow. The early plaques, 
because of their milder tissue reactions and the smaller quantities
15
of cholesterol they contain, are probably reversible although
the regression may take a long time. The fully developed
plaques with more intensive tissue reactions and large quantities
of lipid are probably reversible to a much lesser extent.
The following conclusions may be drawn. The formation of
atheromatous plaques in the walls of coronary arteries initiates
development of coronary heart disease. These lesions consist
of lipid, primarily cholesterol which is believed to be deposited
from the circulating blood. The cholesterol of atheromata is in
81equilibrium with serum cholesterol, and infiltration of the latter
is assumed to be at a rate diz'ectly related to serum cholesterol 
80 82concentration, ' 9 This assumption is supported by a great 
many studies which have clearly shown that patients suffering with 
coronary heart disease have higher serum cholesterol levels than 
healthy subjects, and that the higher the serum cholesterol level 
the higher the frequency of coronary heart disease, or the 
greater the likelihood that it will develop. Other factors such 
as hypertension, greater haemodynamic stress, thrombus formation 
and arterial injury by chemical or immunological agents probably 
assist in the focal deposition of lipid, but the most common 
approach to preventing the development or progression of athero­
sclerosis is by reduction of elevated blood cholesterol levels.
Serum cholesterol levels may be reduced by corresponding reduction
86of dietary cholesterol, by increasing the proportion of dietary
polyunsaturated fat or by the use of drugs which inhibit cholesterol
83 84 43
synthesis Jf or stimulate excretion of bile acids,  ^ Although
it has been clearly demonstrated by use of animals that excessive
serum cholesterol results in significant changes in arterial wall 
8 "7
metabolism, it is unclear whether such changes are due to 
cholesterol itself, since excessive dietary cholesterol results 
in changes in other lipids and proteins of plasma.
16
The information gained so far, relating changes of 
arterial wall metabolism with elevated serum cholesterol levels 
shows many altered metabolic activities. It remains to be seen 
whether the complex sequence of metabolic events in atherogenesis 
of experimental animals can be elucidated in the near future, and 
what pertinence the information has for atherogenesis in man.
1.1.5. Lipids of the artery wall
It has long been recognised that lipids are a major 
component of arterial lesions and much work has been done in 
attempts to determine the chemical composition of such lipids 
and the reasons for their accumulation. Early work in this 
field was hindered by the lack of suitable micro techniques 
enabling separation and identification of small quantities of 
lipids present in lesions of different types. These difficulties 
have been largely overcome by the use of column and thin-layer 
chromatography to separate the major classes of lipid, and by 
the advent of gas-liquid chromatography, which has enabled the 
further separation and identification of individual compounds 
within each lipid class,
Glassification of arterial lesions 
It is essential that prior to a systematic study of the 
lipids= associated with atherosclerosis, the types of lesion 
should be classified in a manner that renders them consistently 
distinguishable. In such a classification it is usual to employ
OO OQ
the method of Bottcher et al. 9 These workers divided their 
material into four groups depending upon the macroscopic 
appearance of the arterial wall, according to the classification 
of the WHO^ as follows:
Stage of disease 0 I II III
fo Phospholipids 61 58 k-2 38
fo Free fatty acids 9 k 1 1
%  Cholesterol 8 13 16 19
% Cholesterol esters 6 12 30 3k
% Glycerides 17 13 10 9
TABLE 2. Average lipid content of aortal extracts at various 
stages of disease.
17
Stage 0 no atherosclerotic lesions present
at a magnification of X10.
Stage I - fatty streaks and/or spots*
Stage II - fibrous plaques anc^ or atheroma.
Stage III - lesions as in II, but with the added
complications of ulceration, necrosis, 
haemorrhage or thrombosis.
The first type of visible lesion, the fatty streak, is defined
A
by the WHO as superficial yellow or yellowish-grey intimal 
lesions which are selectively detected by fat stains. A 
fibrous plaque is an elevated intimal thickening which is firm 
and grey or pearly white, and an atheroma is an atherosclerotic 
plaque in which fatty softening is predominant. A complex 
lesion, Stage III, describes an atheroma with additional changes 
such as haemorrhage, ulceration or calcification.
Lipid changes in arterial lesions
Using the method of classifying arterial lesions described
89above, Bottcher and co-workers have determined the gross lipid 
content of undiseased and atherosclerotic aorta. The major 
lipid classes and the proportions in which they occur throughout 
the spectrum of aortal atherosclerosis are given in Table 2.
As the disease advances from fatty streak to plaques and 
complex lesions, the proportion of arterial total lipid made up 
of free cholesterol and cholesterol esters markedly increases; 
corresponding decreases being observed in the triglyceride,
OO OQ
phospholipid and free fatty acid fractions. 9 The rate of
increase in free cholesterol is considerably less than that for
cholesterol esters, until well developed extensive plaques and
90complex lesions are present. The initial high proportion of
free to esterified cholesterol may be due to selective admission
91or retention of the free form, or alternatively may reflect
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hydrolysis of lipoprotein-derived cholesterol ester in the 
artery wall. As atherosclerosis progresses the increase in
the proportion of cholesteryl ester possibly reflects esterific-
9?
ation in the tissue. It has been demonstrated that poly­
unsaturated cholesterol esters are more easily mobilised from 
tissue implants and exhibit relatively little irritant activity 
on connective tissue than either free cholesterol or its
93monounsaturated esters. It is possible, therefore, that the 
arterial wall actively esterifies the sclerogenic free 
cholesterol. Some substantiation of this proposal is provided 
by the discovery that a cholesterol-lecithin fatty acid
92*.
transferase is present in homogenates of arterial tissue.
The increase in the ratio of free to esterified cholesterol in
advanced lesions may result from a decrease in the capacity of
ql 9 5
such tissue to esterify cholesterol, * combined with an 
increased influx of cholesterol from serum.
Comparisons of the compositions of cholesteryl ester 
fatty acids (CEFA) in extracts of normal tissue with those from 
fatty streaks show considerable differences (Table 3)* The 
CEFA composition of fatty streaks shows considerably higher 
proportions of oleic and eicosatrienoic acids, and lesser
88 96 97
quantities of linoleic acid than either normal tissue or plaques. 9 9
Furthermore, CEFA from plaques and undiseased tissue are similar
98—100
to those of serum cholesteryl esters, implying strongly
that the former are derived from blood* The difference in the 
CEFA composition of fatty streaks and normal tissue can be 
correlated with the observation that lipid in fatty streaks is
primarily intracellular, whereas that in normal intima is located
90 97 101 102
predominantly in the intercellular spaces. 9 9 9 The
implication of this correlation is that in fatty streaks intra­
19
cellular cholesterol esterification together with fatty acid synthesis 
and elongation takes place (the eicosatrienoic acid with which 
cholesterol is found to be esterified is predominantly the
V 103
8,11,14 isomer derived from linoleic acid;.
The observed differences in CEFA composition of fatty
streaks and more advanced lesions can be accounted for in terms
101,102
of intra- and extracellular lipid. Smith and co-workers 
have been able to determine the CEPA of both types of lipid 
present in arterial intima. Their results demonstrate a 
striking difference in the proportions of oleic, linoleic and 
eicosatrienoic acids. The CEPA of extracellular lipid contain 
about 28$ oleate and 40% linoleate which is comparable with the 
proportions in blood lipid (Table 3). The intracellular 
cholestezyl esters contain about 48$ oleate and 14$ linoleate.
Plaques typically contain a large core of extracellular lipid 
and it is possible that the observed changes in CEPA as the 
lesion progresses from fatty streak to plaque are due to a large 
influx of serum cholesterol esters. This would result in 
great excesses of extracellular lipid over that produced by local 
synthesis which perhaps predominates in the fatty streak*
The proportion of phospholipids in arteries decreases as 
atherosclerosis advances (Table 2). However, the increase in 
the quantity of total lipid results in a net increase in the 
quantities of this lipid class. ®9>104,105 fatty acid
content of plaque phospholipid differs from that of serum
phospholipid, and it has been demonstrated that the arterial
106
wall has the capacity to synthesise phospholipid, which may 
explain these differences. A combination of infiltration and 
local synthesis is the most probable explanation of arterial 
phospholipid occurrence.
ISOLATED COMPOUND REFERENCES
5*-chole stan-3^ -ol 107-111
5<*-cholestane-3y0, 5,6y0- triol 112-116'
Cholesta-5,24-dien-3^ -ol 116-120
Cholesta-3, 5-3ien-7*'One 112,121-123
Cholesta-4, 6-dien-3-one 112,123
3/£-bydroxy-chole st-5-en-7-one 107,115,124
Cholest-5-ene-3y£, 7<*-diol 112-114,116,125
Cholest-5-ene-3yf, 7^-^iol 114,116,125
Cholest-5-ene-3^, 24-diol 114,125
Cholest-5-ene-3^, 25-diol 114,115
Cholest-5-ene-3^, 26-diol 124^128,111,115
Cholest-5-ene 129
Cholesta-3,5-diene 129
Squalene 124,126,129,131
1,3,5“trioxanes 130
G-lyceryl ether diesters 130
Cholesterol hydroxy-octadeoadienoates 125,127
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Minor Lipids of Arterial Lesions 
The presence of small quantities of other lipids in 
diseased arteries has long been recognised. The human aorta 
with its obvious relationship to atherosclerosis has been the 
subject of considerable study, much of which has been directed 
towards the identification of minor quantities of sterols 
occurring with cholesterol. Earlier workers using classical 
methods of separation and identification required large quantities 
of extracted lipid. Since accumulation of such large quantities 
frequently necessitated storage of tissue or extracted lipid, 
the possibility that several of the minor sterols identified in 
arterial lipid were artefacts must be considered. More recent 
work based on mild chromatographic techniques, has enabled 
both confirmation of some earlier findings and also the 
identification of several new constituents. The minor lipids 
isolated from human aorta are listed opposite. Other sterol
115
and sterol-like components present in the aorta remain unidentified.
The origin of several of the trace sterols is questionable, since
many of them are also products of the air autoxidation of
cholesterol, and the possibility that they may be artefacts
remains unsettled. Of the sterols found, desmosterol,
cholestanol, 26-fcydroxycholesterol and 24-bydroxycholestarol are
the most likely to be genuine aortal constituents. Desmosterol
has been found in substantial quantities in the arteries of
117-120
patients treated with Triparanol, a drug formerly used
to control serum cholesterol levels by blocking the 24-reductase 
in the metabolism of desmosterol to cholesterol/ 24-Hydroxy-
132 *’30cholesterol has been identified as a minor sterol in brain tissue, '
and 26-lydroxycholesterol seems to occur in human arterial tissue
u 4.1, „ 111,124-328,.whether normal or diseased, its quantities increasing as
21
atherosclerosis progresses. Cholestanol has been identified
as a companion of cholesterol in many animal tissues including
human arteries. The quantities in which this sterol occurs in
arteries hare been disputed, estimates ranging from 13$ of the
108total sterols by early workers, to 0.5$ in more recent 
109investigations. The occurrence in advanced aortal lesions
125 127of hydroxylated sterol esters has been reported, * These
esters may be distinguished as a) a group of hydroxycholesterols 
mono-esterified with normal saturated or unsatured fatty acids, 
and b) a group consisting of cholesterol esterified with several 
different hydroxy fatty acids. The origin and possible role 
of these esters in the pathogenesis of atherosclerosis will be 
discussed later.
TECHNIQUES OF LIPID ANALYSIS
Thin-Layer Chromatography
Since its discovezy in 1938^^ and the much more recent 
realisation of its potential,134-137 thin-layer chromatography 
(TLC) has become an invaluable technique throughout the realm of 
organic chemistry, and most particularly in the field of analysis 
of biological extracts. The use of TLC is so widespread and 
has so many applications that only the principles of the technique 
and the aspects particularly relevant to the present work can be 
mentioned,
TLC is used in lipid analysis mainly as an adsorption 
technique in which the adsorbent is coated as a thin layer 
(generally 100 -1000/u) on an inert support. The material to be 
separated is applied to the adsorbent and eluted with solvent.
The moving substances are separated by their differing adsorption 
coefficients in the equilibrium established at the adsorbent/ 
solution interface. Pure adsorption chromatography is an ideal 
case. Almost invariably some degree of partition chromatography 
occurs, though it is dependent upon the natures of both the 
adsorbent and the material being chromatographed.
The types of adsorbents used in TLC vary considerably.
Silica gel is the most commonly used, since it is suitable for 
almost all types of lipid class separations, and also because it 
wa3 the first material to become commercially available. It is 
normally supplied containing about 1C$ calcium sulphate as a 
binder which confers on the layer considerable mechanical stability. 
Neutral alumina has much the same separating characteristics as 
silica. Calcium sulphate, calcium phosphate and charcoal are 
amongst other materials which have also been used, ^ 8
In 1959 Mangold^ ^  first employed TLC for lipid analysis.
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Using layers of silica gel he found that TI£ was capable of 
separating the major lipid classes in a manner similar to that of 
silica gel column chromatography. Since then TLG has been used 
extensively for lipid separation and characterisation. These 
applications have been reviewed by Mangold, M o r r i s a n d  
Kirchner.
TLC has several advantages over adsorption column chromato­
graphy, The latter is usually used as an elution technique where 
fractions are removed stepwise from the column, and subsequently 
analysed. In TLC, however, the development is limited and the 
processes of separation are more easily observed, TLC lends 
itself particularly well to analyses of very small quantities of 
material. In the present work preparative TLC on microscope slides 
enabled successful separation and recovery of between 5 and 20/< g 
of lipid samples. The speed with which analytical chromatograms 
are produced can be used to monitor successive fractions eluted 
during column chromatography of biological extracts. A major 
disadvantage of TLC is that the quantity of material which may be 
applied to a chromatogram is limited bjr the thickness of the 
adsorbent layer. For an adsorbent of silioa gel, one 20 x 20 cm 
plate with a layer thickness of 50Cy*will accommodate J>0 rag of 
material without impairment of separating efficiency. However, 
the separations on thicker layers (1000-2000/*) are distinctly 
inferior to those obtained with thicknesses of 100-500/*, If minor 
constituents are to be isolated from a complex mixture, it is 
advisable to pre-fractionate the mixture by column chromatography 
and then to purify the required fractions by TLC. A fora of
column chromatography has been developed which uses a limited 
development technique on silica gel identical to that used for 
TLC, This method permits the use of much larger loads than
can be accommodated by conventional TLG, while retaining most of
2k
the advantageous aspects of the latter. An important aspect of 
TLC! is the use of adsorbent layers modified by the addition of 
complexing agents such as silver nitrate and boric acid. Un- 
saturated lipids form complexes with silver ions due to the 
interaction of the filled 1T orbitals of the olefin with the empty 
s orbital of the silver ion, and electron transfer from the filled 
d orbitals of the central ion to the vacant 1T antibonding orbitals 
of the olefin. ^ 1 The presence of silver ions in the layers 
causes unsaturated species to be less mobile than the saturated
analogues, and compounds can be separated on the basis of the
327
number, type or position of the double bonds. Hence fatty acids,
cholesterol esters, triglycerides and sterols may be separated
according to their degree of unsaturation. The uses of silver ion
1L1chromatography have been reviewed by Morris. Boric acid
impregnated silica gel has been used for the successful separation
1 i t 11 r
tfrTQO erythro dihydroxy fatty acid methyl esters, * ^
1M?while layers containing urea ^  enable the separation of straight- 
chain and branched-chain fatty acid esters.
TI£ is capable, if used with care, of supplying physical data 
of use in the tentative identification of samples. This involves 
direct comparison of the mobilities of a sample with those of 
reference compounds, and observation of the reactions of the spots 
on the developed chromatograms with various detecting agents.
The mobility of a spot on TLC is most commonly recorded as its Rp 
value which is defined as the ratio of the distance moved by the 
material from the origin, to the distance moved by the mobile phase. 
Improved consistency of retention data can frequently be obtained 
by measuring the mobility of the sample spot relative to that of an 
internal reference standard. ^ 7
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Spot detecting agents for TLC
In a brief discussion of the techniques and reagents used to 
visualise spots or bands on developed chromatograms, it is 
advantageous to consider separately the preparative and analytical 
aspects of the technique.
TLC used analytically does not necessitate the recovery of
the sample after development of the chromatogram. It is common
practice, therefore, to spray the chromatogram with reagents which
react with material on the plates to produce coloured spots. These
reagents can be classified into those which react non-specifically
with most compounds, and those capable of specific reaction with
certain compounds or functional groups. A large number of the
spray reagents used for sterol and steroid localisation on TIC
have been reviewed by Lisboa. The applications of the anisalde-
149
hyde-sulphuric acid reagent of Ekkert have been investigated for 
more than 250 steroids of the estrane, pregnane and androstane 
series. The colours developed in the reactions of this reagent 
with various steroids depend on the intensity of spraying and the 
temperature and duration of heating, and are capable of yielding 
valuable information enabling the differentiation of sterol classes 
and stereoisomers. The reagent used most frequently in the present 
work was a solution of 5% eerie sulphate in sulphuric acid which 
was found to permit differentiation of most of the sterols and 
sterol esters found in arterial tissue (Appendix i). Spray reagents 
which react specifically with compounds containing particular 
functional groups are frequently of value. Reagents of this type 
include 2,2f-dinitrophenylhydrazine in acidic ethanol for the 
detection of free aldehydes and ketones, aqueous ferric chloride 
(for phenols and carboxylic acids), potassium iodide-starch 
solution (for peroxides), and ninhydrin in butanol (for phosphatides
2 6
and lipids containing a free amino group). Sterols containing the 
5-ene-3/0-ol system may be fairly selectively differentiated from 
other ■types by exposure of developed chromatograms to hydrochloric 
acid vapours. 152,331 comprehensive list of spray reagents for TLC
is given by Stahl.
It is normally desirable when using preparative TLC that the 
chromatographed material should be recovered unchanged from the 
developed chromatogram. Destructive methods of locating bands 
on preparative chromatograms are therefore unsuitable. In 
consequence alternative methods of detection have been developed.
A solution of 2,7-dichlorofluorescein is frequently employed. After 
spraying, bands may be detected by their fluorescence when viewed 
under ultraviolet light. A modification of this method involves 
the use of silica gel containing a fluorescent dye. When the 
developed chromatogram is viewed under ultraviolet light the
adsorbed material is visible due to quenching of the fluorescence
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in the layer/ Another commonly used method of band location entails
exposure of the chromatogram to iodine vapour. A brown colour
results with many organic compounds. This method is non-destructive
with most compounds, though prolonged exposure of polyunsaturated
lipids to iodine should be avoided. It has recently been
reported that a solution of primuline in aqueous acetone is an
effective reagent for the non-destructive location of some lipids 
153and steroids.
Use of derivatives in TLG
Until fairly recently the quantitative elution of compounds
150containing more than one hydroxyl function has proved difficult.
The use of derivatives such as acetates, propionates and trimethyl- 
silyl (TMS) ethers can allow very high recoveries from preparative 
chromatograms, as a result of the much reduced polarity of such 
derivatives. TMS ethers deserve special mention. The usefulness
of these compounds as derivatives for TLG has not been widely
appreciated, probably because of an earlier misconception that
TMS ethers were vezy readily l^ ydrolysed. Although the derivatives
of phenols are easily hydrolysed, those of alcohols are
comparatively stable. TLC of TMS ethers of poly-hydroxy sterols
has enabled recoveries of better than 90fo from preparative
chromatograms.^^ Effective separations of individual sterols,
in particular of epimeric pairs can also be obtained by TLC of
1 "16their trimethylsilyl derivatives.
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1.2.2. Gas-Liquid Chromatography
Gas-liouid chromatography (GLC) has become an invaluable
tool in biological and medical research. This highly sensitive
technique permits rapid fractionation of complex mixtures, and
provides both qualitative and accurate quantitative data.
GLC involves partition of a volatilised sample between a
mobile gas phase and a stationary liquid phase coated on an
inert support. The components of a mixture are separated in the
gas phase and individually detected. The extensive use which
has been made of GLC in the biological sciences is due mainly to
the development of highly sensitive detectors, and a large variety
of thermally stable liquid stationary phases. The first high
sensitivity detector was the argon ionisation type developed by 
15kLovelock, which is capable of detecting solute in carrier gas
in concentrations as low as 10"^ g/ml. It is, however, very
susceptible to impurities such as oxygen and water vapour, which
reduce its efficiency in detecting organic compounds. The most
common detector in use today is the lydrogen flame ionisation
type which is just as sensitive as the argon type, and does not
suffer from the disadvantages mentioned above. Other detectors
such as the electron capture, the flame photometric and the
thermionic types have been developed and each has its particular
detection characteristics. In the technique of combined GLC-mass
spectrometry (GO-MS), the mass spectrometer is used as a detector,
and can be applied to the specific detection of compounds producing
ifio
characteristic mass spectral ions.
There is an extensive variety of stationary phases which 
may be used in GLC. Probably the most popular are those of the 
siloxane polymer type. These are particularly useful due to 
their considerable thermal stability, and because variation of the 
substituent in the polymer affords useful changes in the separating
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characteristics of the liquid phase.
The methyl siloxane polymers such as SE-30, JXR and OV-l, 
are fairly "non-selective" and effect separations based more or 
less on differences in molecular weight. Complete or partial 
replacement of methyl with phenyl substituents gives stationary 
phases in which dipole interactions with olefinic bonds in the 
samples frequently permit the separation of closely related 
compounds. Fluoroalkyl siloxane polymers can selectively 
separate ketonic compounds from alcohols. The phases most 
commonly used in fatty acid ester analyses are the polyesters, 
which separate acid derivatives with the same number of carbon; 
atoms on the basis of their multiple bond content. Though of 
considerable value, such phases have rather low thermal stability 
and separations generally necessitate the use of packings containing 
a rather high proportion of polyester. Several interesting thermo­
stable stationary phases have recently become available. Poly-m-
155 156 157phenoxylene, polyamides, polyimides, and carborane
158polymers ^ are typical examples. Among them the poly-^j-carborane
siloxanes exhibit thermal stability which cannot be challenged by
159any of the other materials which are presently available.
The amount of information obtained by GLC may be greatly 
increased by the formation of suitable derivatives. Many substances 
such as sugars, amino acids and carboxylic acids are, because of 
their highly polar nature, unsuitable for direct analysis. In 
such cases derivative formation is essential. In other cases 
improved chromatographic resolution and greater thermal stability 
may be obtained by derivative formation. Some of the more common 
derivatives are listed below:
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Functional Group Derivative
ALCOHOL
Acetate 
Propionate 
Methyl ether 
Trimethylsilyl ether 
Trifluoroacet ate 
Hept afluorobutyrate
CARBONYL 0-Methyl oxime Trimethyls ilyl oxime
CAHBOXYLIC ACID Methyl ester
AMINE
Acetyl derivative 
Heptafluorobutyiyl derivatives 
Trimetlylsilyl ether
Trimetbylsilyl (TMS) ethers are particularly good derivatives^
for G-LC ~ and have been found especially useful in studies
of sterols. They have excellent chromatographic properties,
exhibiting high thermal stability and volatility, and in most cases
are vezy easy to prepare. Moreover, IMS ethers are found generally
165to yield informative mass spectra, in certain cases affording
highly characteristic modes of fragmentation from which structural
165 166-169details may be inferred. ~ y Some aspects of their mass
spectral behaviour will be described in Section 1.2.3.
The parameters usually measured in GLC are the retention 
time, the temperature of separation, the carrier gas flow rate and 
the quantity and type of stationary phase used. Since several of 
these parameters are variable, it is normal to relate the retention 
time of a sample to that of a suitable reference standard. For 
steroids of the cholestane series, the reference material usually 
employed is the hydrocarbon 5«-cholestane. Relative retention 
times (at constant temperature) are expressed as the retention
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time of the sample divided by that of the standard. In isothermal 
GLC a linear relationship exists between the number of carbon atoms 
in the members of a homologous series and the logarithm of their 
retention times. In contrast, temperature programming gives an 
almost linear relationship between the carbon content of homologues 
and their retention times. Such correlations may be applied to 
measurement of retention data. In fatty acid analyses retention 
values are generally related to those of a homologous series of
170,171
fatty acid methyl esters. Components in a mixture of sample
acid esters are assigned equivalent chain length (eel) values which
/ 172are highly reproducible, Kovats has devised an index scale
based on the retention times of the n-alkanes. The retention 
times of these compounds are converted into index values according 
to their carbon number (i.e. methane a 100, ethane a 200, 
pentadecane = 1500, etc,), and samples are assigned retention index 
(i) values according to their retention times relative to the 
adjacent n-alkanes. This technique takes advantage of the high 
degree of repeatability of separation on a given column, and permits 
comparison of separations on columns prepared and used in different 
laboratories. The Kovats system is used exclusively in the present 
work.
Applications of QLO 
Biological research is a field in which the analysis of 
minute amounts of highly complex mixtures may be essential for the 
solution of many problems, and GLC has been used extensively to 
analyse natural lipids such as steroids and fatty acids. In 
connection with atherosclerosis, the relationships between chemical 
composition of the artery wall and pathological change have been 
largely established by comparison of the fatty acid composition of 
diseased and undiseased tissue.^8,96,100 q^q is particularly
applicable in such cases, since it may be used as a semi- 
quantitative technique to estimate the relative proportions of the 
individual acids in mixtures derived from glycerides, sterol esters 
and phospholipids. The identity of fatty acids of unknown 
structure can frequently be inferred by their comparison with 
reference compounds on several different stationary phases.
During work on small quantities of lipid, it is important 
to bear in mind that plasticisers and other impurities which occur 
in solvents,1^  plastic tubing,1^  filter paper, etc., may cause 
serious interference in chromatograms of fatty acid methyl esters. 
This problem has been encountered in the present study and is 
further discussed in Section 2.
The discoveiy that steroids could be separated by GL£ was 
175made in I960. Due to the development of the large number of
thermally stable stationary phases and the application of 
derivatives (especially TMS ethers and O-Metlyloximes), GLC has 
become established as virtually the only practical method of 
simultaneous separation, identification and quantification of the 
complex mixtures of steroids obtained from sources such as blood 
or urine. Urine contains many steroid metabolites which are the 
end products of a complex set of metabolic relationships. It 
was soon realised that ’’urinary steroid profiles" could be correlated 
with pathological change and drug administration, and many studies 
have been made of urinary steroids in normal and pathological 
cases,^76,177 Quantitative determinations of testosterone, 
estrogens, adrenal corticosteroids and progesterone metabolites 
in urine samples have been developed into routine procedures by 
the use of GLC. A major problem in work of this kind is the 
interfering compounds in the sample. The trends in recent research 
have generally been in the direction of developing more efficient 
or elaborate methods of purification, to increase the reliability
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160
of the final analysis. The use of the relatively new single
!76p7%228
ion and multiple ion monitoring techniques affords a very
promising method of sensitive and highly specific detection.
GLC also offers a practical method for analysis of bile acids in
180 181serum and other body fluids. * The use of electron capture
detectors has enabled the detection of as little as 0.1 ng of these
182compounds as their methyl ester trifluoroacetates.
Unknown steroids may be tentatively identified by GLC. It 
is observed that the influence upon retention time of substituents, 
or other modifications of the steroid structure can frequently be 
described in a simple mathematical way. This makes it possible 
to determine with considerable precision the retention time of a 
sterol not yet known, provided that data are available on the 
effect of each substituent of the molecule as well as the basic
A 07 ,j 0*7
sterol structure. However, the use of several different
stationary phases is advisable if useful identifications are to be
made in this way.
Whereas earlier gas chromatographic analysis of lipids such
as glycerides and sterol esters normally entailed hydrolysis of
the sample and separate examination of the acyl and neutral
constituents, the development of stationary phases of very high
thermal stability has recently permitted direct examination of the
188-190
intact lipids. Kuksis has successfully separated tri­
glycerides and sterol esters originating from a variety of sources 
on several siloxane polymers. Naturally occurring diglycerides 
and those derived from phospholipids may be separated as the free 
compounds or as TMS ethers. Analyses of high molecular weight 
lipids have been reported using open tubular columns coated with 
carborane polymers.
The potency of GLC may be increased considerably if used in 
association with other chromatographic or analytical techniques.
3k
Occasionally separation of closely related compounds cannot "be 
effected by GLC, and recourse must be made to alternative chromato­
graphic methods* The isomeric and steroids present
this difficulty, but in some cases TLC on silver nitrate 
impregnated layers may resolve these isomers, which can be 
subsequently characterised by GLC. During work on mixtures of 
octadecadiene-1,9- and -1,13-diols, we found GLC capable of 
separating cis.trans from trans, trans derivatives, but unsuitable 
for the resolution of the positional isomers* However, the latter 
are readily separated by TLC, and complementary use of both 
techniques permitted the mass spectral analysis of the individual 
components. The use of GLC in conjunction with mass spectrometry 
has become increasingly important in lipid research, and will be 
discussed in the following Section.
X: ; r
35
1.2.3* Application of Combined Gas Chromat ography-Mass Spectrometry to 
Lipid Analysis.
Although chromatographic methods can yield important evidence 
for the identification of an unknown compound, complete character­
isation solely ty chromatographic methods is seldom feasible.
Where the available sample is small, few techniques are as useful 
as mass spectrometry in providing detailed structural information* 
The use of mass spectrometry in conjunction with GLC permits 
direct correlation of chromatographic and mass spectral properties 
for individual components in very small samples of complex mixtures. 
Combined gas chromatography-mass spectrometry (GC-MS) is therefore 
particularly useful for studies of naturally occurring lipids.
The potency of GC-MS may be exemplified by consideration of the 
complex nature of naturally occurring lipids. In most cases use 
of GLD alone requires very extensive and tedious calibration. 
Application of mass spectrometry to such mixtures can afford only 
generalised summaries of grouped structure. Together GC-MS 
techniques provide rapid and detailed composition analysis,
GC-MS has found considerable application in the analysis of
AQp^jQ^
mixtures of naturally occurring fatty acids and alcohols,
and is especially useful for the location of functional groups in
197-199
such compounds. Studies by Odham of the branched chain
200,201
fatty acids isolated from feather waxes represent a good
example of the usefulness of mass spectrometry in the structure 
determination of such compounds.
The success of mass spectrometry for the analysis of lipids 
and in particular of steroids has been largely due to the discovery 
of derivatives affording protection for labile functional groups, 
and promoting regular patterns of fragmentation. In GC-MS 
derivatives are chosen which also give good gas chromatographic 
characteristics. For most hydroxylated lipids, and especially
for sterols such a derivative is the trimethylsilyl (TMS) ether.
165
These derivatives were introduced by Sharkey in 1957 with the
object of obtaining more abundant molecular ions than were normally
obtained with sterols or their esters, and were subsequently found
202to have very good gas chromatographic properties. Probably
the most valuable feature of TMS ethers is their tendency to
promote well defined fragmentation modes, with the formation of
rather stable trimethylsilyl oxonium ions, For example, when a
TMS ether group occurs in a straight chain, compound such as a
hydroxy fatty acid, or in the side chain of a sterol, the following
203-207type of fragmentation is typical,
tOTMS o
R^H2)i^ (SH2)5 OCH:
OTMS OTMS 0
/  \ II II /  \  V
R-(C H ) C H CH (C H J  C O C K
x 2/m v 27n
Such fragmentations are extremely useful for characterisation of
192long chain compounds such as fatty acids. Hydroxyl functions
may be located in the chain by formation of TMS ethers and 
subsequent mass spectral a n a l y s i s . T h e  usefulness of TMS 
ethers may be extended to determine the positions of multiple bonds 
in fatty acids, which cannot nomally be inferred from GLC or 
mass spectrometry of the acids themselves. Oxidation of olefinic 
bonds to the vicinal diols, and mass spectral analysis of the TMS
ethers has been used to determine the positions of olefinic bonds
203,20k,208,209 ... . . . « .. 210-212 ..m  mono- * * ’ and di-unsaturated fatty acids.
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The major disadvantage of these derivatives for olefinic bond
location in polyunsaturated acids is that they greatly increase
the molecular weight of the compounds, Consequently the use of
polymethoxy derivatives, though affording somewhat less
213
characteristic mass spectra, is often preferred, Abley et al.
have described an alternative method from double bond location
in mono and dienoic acid esters by reduction of methoxymercuration
products with sodium borohydride and analysis of the products by
GC-MS. The structures of the mono-hydroperoxides of methyl
oleate have been determined by mass spectral analysis of the
trimetbylsilylated hydroxy-esters obtained by reduction of the
206
autoxidation products. These derivatives were found to yield
highly informative mass spectra which readily enabled the location
of both the hydroxyl function and the double bond. In the present
215
work mass spectrometry of the octadecadienediol bis TMS ethers
derived from oxygenated cholesteryl linoleate proved a satisfactory
approach to their structure elucidation on a microgram scale.
The mass spectra of sterol TMS ethers are in many cases
highly characteristic. Those of the^ Si -3-trimethylsilyloxy sterols
contain a very abundant ion at n/je s 129. This fragment has been
shown to comprise the TMS ether group and carbon atoms C(i),
"t69 217
C(2) and of the steroid nucleus, * and the following
mechanism has been proposed to explain its occurrence:
TMS
TMSO
n & = 1 2 9
* .
TM SO Ch ^ J
TMSCT rfp*
H
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17-Trimethylsilyloxy steroids of the androstane and estrane series
also give this ion, but may be distinguished from the4^-3-trimethyl-
169 217 218silyloxy steroids which also give an intense ion at M-129. * *
The trimetfcylsilyl ether of ^ ^-cholesten-3^~ol has a mass spectrum 
strikingly different from that of cholesterol. In this case ions 
are observed at = 1A3 and 1if2, and mey be respectively ascribed 
to fragments comprising the -OTMS attached to a four carbon unit
218
from ring A, and the product of a retro-Diels-Alder fragmentation. 
Mass spectrometry thus affords a valuable distinction, since it is 
difficult to separate A**"- and A  ^ -sterols by GLC, The^^>^ sterols 
(e*g. 7-dehydrocholesterol and ergosterol), may also be readily 
identified by mass spectral analysis of their TMS ethers which show
nA o
characteristic ions at n/13 = 131 and M-131* New derivatives
of steroids, affording thermal stability and characteristic modes
of fragmentation useful for identification of natural steroids
and drug metabolites, are being developed and evaluated, Baillie 
219and co-workers ' have evaluated several derivatives suitable for
GC-MS analysis of corticosteroids which, when chromatographed as
the free sterols, generally undergo considerable decomposition.
220-222Of particular interest are the cyclic boronic esters.
The formation of a cyclic boronic ester transforms the labile 
dihydroxyacetone side chain as exemplified for cortisone:
=0 B-R
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Cyclic esters with R representing methyl, n-butyl, t-butyl,
cyclohexyl and phenyl have been shown to be satisfactory derivatives
223
for GCrMS of a variety of corticosteroids. Their most
valuable features are the general prominence of molecular ions,
and of ions characteristic of the corticosteroid side chain
involved. However care must be exercised during the preparation
of these derivatives, since excesses of reagent may have
detrimental effects, and probably the best "all round" derivatives
for corticosteroid analyses are the methyl oximes and TMS ethers.
A recent and important modification of GC-MS is the "single
ion monitoring" technique whereby particular compounds may be
detected by means of a small set of characteristic ions in their 
22^-228
mass spectra. In suitable instances the detection of one
ion of particular u/e_ value may afford a means of detecting and
160,222,229,216
estimating steroids at very low concentrations.
Application of this technique is of particular importance for
studies of drug metabolites having similar structural features
which are reflected by characteristic ions in their mass spectra.
TMS ethers of steroid drug metabolites containing 17*-alkyl-,
17«-alkeny1-, and 17°<-alkynyl-17^ - ols may be detected selectively
by the abundant ions at n)/e = 128+R which in general do not occur
222in the mass spectra of natural steroids.
OTMS
v
OTMS
%  = 128+R
Using these techniques a preliminary study has been made of the
urinary neutral metabolites of the anabolic steroid, 17s*-ethyl-
22 21 lJff-hydroxyestr-if-en-3-one,
4-0
GC-MS has been used extensively to identify steroids of
biological origin. One especially important application of the
technique is the determination of urinary steroid profiles and
176,230
their relationship with physiological and clinical symptoms.
Particular care must be given in such studies to accurate
correlation of retention data with mass spectra, since diastereo-
isomers with identical mass spectra are frequently encountered.
By application of raicrochemical techniques in conjunction with
231
GC-MS, J. and K, Sjovall identified 2ju.g of 5<*-pregnane-3«S 20*»
21-triol from human pregnancy plasma. No authentic reference
sample was available and the configurations at 0^^  * ^(5) an^
C(20) were elegantly deduced from gas chromatographic data.
The complexity of natural lipid samples requires that
powerful tools must be available for their analysis. GC-MS is
a highly efficient technique for analysing such mixtures. The
application of GC-MS to analysis of complex mixtures presents
new problems, in particular handling and interpretation of the
large amounts of data produced. The use of computers for reading
226 232
and calculation of mass spectra is being increasingly applied. *
Section 2 EXPERIMENTAL METHODS
SOLVENTS
Most of the present work was carried out using 
"Nanograde” solvents (Mallinckrodt Chemical Works, St, Louis, 
Missouri,), When these were not available, solvents of 
analytical grade were used and these were distilled prior to 
use. Diethyl ether was redistilled over ferrous sulphate to 
remove alkyl peroxides,
INTEHFERBNCE OF PLASTICISERS DURING- LIPID ANALYSIS 
Introduction
The hazards attached to the use, in micro scale analysis, 
of solvent^ re agent s^+? unestablished purity are
fairly well realised. The occurrence in biological extracts
of plastioisers, in particular di-n-butyl phthalate has been
174,235-237
described by several investigators, and it may be
concluded that the only way of ensuring that extracts remain 
free of such contaminants is by careful and routine examination 
of solvents and all other materials with which the sample may 
come in contact. During examination of the fatty acids 
occurring in diesters of 26-hydroxyeholesterol, gas chromato­
graphic analysis of fatty acid methyl esters frequently indicated 
the presence of a constituent whose chromatographic behaviour 
was inconsistent with that of any ester expected to be present 
in such fractions. Comparisons using GLC and mass spectrometry
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of this material with authentic di-n-butyl phthalate indicated 
identical behaviour. In order to determine the mode of entry 
of this contaminant into our extracts, all solvents, silica gel, 
drying agents and boiling stones used during our chromatographic 
sequences were analysed to determine the quantities of 
plasticisers present in such materials.
k3
2.2.2* Determination of the quantity of di-n-butyl phthalate in 
solvents and other materials.
100 ml of the solvent to be analysed was reduced to 
dryness under vacuum. The residue was dissolved in etl^ yl 
acetate, transferred to a small tapered vial, and solvent was 
removed in a stream of nitrogen. The residue was dissolved 
in ethyl acetate (lO.Oyiil) delivered via a Hamilton syringe. 
Reference solutions of di-n-butyl phthalate vaiying in 
concentration from 0.2 mg/ml to 3*0 mg/ml were prepared, and 
lju 1 aliquots of these were successively examined by G-LC (5* 
column, 1$ 0V-17, 200°G.). Two injections were made at each 
concentration, the mean peak heights were measured and a graph 
of peak height versus quantity injected was obtained* The 
graph was found to be linear over the range examined (0.2-3 
1 jil aliquots of the solutions of solvent residue were injected, 
and from the peak height (mean of two determinations) the 
quantity of di-butyl phthalate represented in the chromatograms, 
and thus the quantity/1 of solvent was calculated. Samples 
of silica gel (both that used for TLC and column chromatography) 
sodium sulphate, used as a drying agent for solutions in organic 
solvents, and boiling stones were weighed, and refluxed for 
30 min. in ethyl acetate (redistilled, 100 ml). The solutions 
were filtered, the filtered material was washed with hot 
redistilled ethyl acetate, and the filtrate and washings were 
combined. The ethyl acetate solutions were concentrated as 
described above: aliquots were examined by GLC, and the degree
of plasticiser contamination was determined.
Full results are presented in Appendix II. Although the 
quantities of di-butyl phthalate in unredistilled analytical 
grade solvents are not in general excessively high (30-120/tg/l),
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the use of perhaps 400 ml of total solvent during an analytical 
process, from the stage of tissue extraction to that of 
examination of fatty acid esters by GLC, is sufficient to cause 
serious contamination of veiy small quantities of sample. The 
use of redistilled or "Nanograde " solvents greatly reduces the 
risk of extract contamination. Chromatography on silica gel 
of high purity, and the pretreatment of drying agent, are also 
advantageous.
2.2*3* General precautions for the prevention of sample contamination.
(a) All containers and apparatus for storage and manipulation 
of sample were made of glass. Materials such as rubber 
or plastic were avoided.
(b) Drying of solutions in organic solvents.
Solutions were dried with analytical grade anhydrous sodium 
sulphate, previously washed with hot "Nanograde" ethyl 
acetate, and dried at 150°C in a vacuum oven.
(c) Glassware.
After washing and drying, glassware was stored with arms 
and necks covered by clean aluminium foil to prevent entry 
of dust. Prior to use glassware was rinsed twice with 
small quantities of "Nanograde" or redistilled solvent.
(d) Sample storage.
Samples were stored in ^ -dram screw cap vials with aluminium 
foil faced seals which had been rinsed with attested solvent. 
All lipids, both reference compounds and extracts were 
stored in darkness at -20°C. Solutions of lipid were in 
hexane or ethyl acetate.
(e) Filtration
Small volumes of solvent (0.5-5ml) containing insoluble
material were filtered through either thin glass tubes fitted 
with glass sinters, or through pasteur pipettes fitted with 
plugs of clean, solvent washed cotton wool. Larger volumes 
of solvent were filtered by gravity through solvent washed 
filter paper.
(f) Removal of solvent.
Small quantities of solvent were removed by exposure to a 
stream of oxygen-free nitrogen. Nitrogen was delivered to 
the vial or flask via a pasteur pipette plugged with a small 
pad of solvent washed cotton wool. Volumes of solvent 
greater than 10 ml were generally removed under vacuum using 
a rotary evaporator. No evidence was obtained to suggest 
that the careful use of this apparatus could contribute to 
sample contamination.
TISSUE PREPARATION AND EXTRACTION 
All arterial tissue used in this work was obtained through 
Dr. W.A. Harland, Department of Pathology, Western Infirmary, 
Glasgow, G12 8QQ. Aortas were obtained at post mortem examination 
and were processed within 24 hours after death. The vessels were 
opened longitudinally and washed with water or sodium chloride 
solution to remove adhering blood. The three arterial layers, 
intima, media and adventitia were clearly visible, and the latter 
two were stripped from the intima. Lesions were graded according 
to the W.H.O. classification (Page 17), and lesions of similar 
grade were collectively processed. In severely diseased aortas 
the intima displayed considerable thickening, and the separation 
of intima from media presented no difficulty. Separation of the 
two layers in samples affected only by fatty streaks was more
2.W.
difficult, and the intima obtained in such cases frequently- 
contained small quantities of medial tissue* After collection, 
tissue was finely divided using scissors and extracted in 
chloroform:methanol (2:1 v/v) for fifteen hours at -20*^ 0 in an
atmosphere of nitrogen* The solvents used for the extraction
239 2!fX)
of "total lipid" from tissues have been extensively discussed * 
and the use of chloroform: methanol mixture appears to be generally 
preferred* The extract was filtered by gravity, the pieces of 
tissue were washed with small quantities of chloroform:methanol 
mixture, and the filtrate and washings were combined. The 
extract was reduced to dryness under vacuum using a water bath.
The temperature of the latter did not exceed ifO°G. Benzene: 
ethanol (l:l v/v) was added to reduce frothing and aid removal
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of water. The residue was dissolved in a mixture of diethyl
ether: hexane (l:l v/v) and the solution was washed with an 
appropriate volume of distilled water, to remove non lipid 
constituents. 2k° The organic layer was dried, solvent was 
removed under vacuum, and the extract was weighed. The lipid 
residue was dissolved in hexane and subjected to silicic acid 
column chromatography.
COLUMN CHROMATOGRAPHY 
Column chromatography of lipid extracts was performed 
initially on Mallinckrodt Silicic Acid 100 mesh, sieved to 100- 
200 mesh, and acid washed and dried according to the procedure 
of Homing. Subsequently, SilicAR cc-4, 100-200 mesh 
(Mallinckrodt), was employed and the sieving and acid washing 
procedures were discontinued. The drying procedure described 
in Ref 2^ 2 was still used in order to obtain material of a
LLl
u
if)
CL
.Oo
O
h co
o
z
.otn z
o
h*
o U'V <cr
u-l
-O
t o
CL LLl 
I—LO .niu 2
>- to |XJ 
x cc I- 
O LU W
CL I-  LU 
Ltl tO >. D- UJ C
Q 8
Off Q |- Q 
>  uj >  X  X
Q.
X
to
a;
Ll!
h-to
to ^
z  _JO o 
m aUl 
< H 
O  lo 
O lli 
CL -J 
o  O 
>- X  
X (J
to 
_J O
o
2 y
^ w
UJ 5  
_J <
O -J x  O 
o  -
.. to 
L) Q-
. j
O
CLUJ
H
tO
UJ
Q  to 
z  to uj 
9 cc 9
x  LU cc 
o  H- UJ 
a: ^  O
q  uj >i
^ Q O
-OCM
UJ UJ
x (j o
9
a:
h-
O
h“
I-
Z
UJ3
_J
UJ
Ul Ul
z Z  u>< <X XUJ UJ
X X  ^
< 3 6
0X
u
0
0
to O ^  O l o O i o o w O l o , .
X
u
co u
<
O
+->
UJ
FI
G
, 
1, 
Ty
pi
ca
l 
el
ut
io
n 
pa
tte
rn
 
ob
ta
in
ed
 
du
rin
g 
s
ili
c
ic
 
ac
id
 
co
lu
m
n 
ch
ro
m
at
og
ra
ph
y 
of 
lip
id
s
 
fro
m
 
a 
se
ve
re
ly
 
di
se
as
ed
 
ao
rt
a
.
consistent degree of activity.
Chromatography of lipid extracts was performed in glass 
columns fitted with glass sinters and stopcocks. The size of 
the column and the quantity of silicic acid used were determined 
by the quantity of lipid to be chromatographed, and a load of 
approximately 20 mg lipicj/g of silicic acid was used. The 
column was packed by pouring a slurry of the specially treated 
silicic acid in hexane into the glass column which also contained 
hexane. The evenly packed column was washed with 500 ml hexane 
prior to the addition of the lipid extract. At the stage an 
eluate of 100 ml was collected to serve as a blank. A solution 
of the lipid extract in hexane was added gently via a Pasteur 
pipette to the top of the column, which was wrapped in aluminium 
foil to minimise possible light-induced artefact formation during 
chromatography. Chromatography was commenced by elution with 
hexane, continued with chloroform-hexane mixtures, and completed 
with ethyl acetate. In general 50 ml eluates were collected.
The order of elution of different classes of neutral lipid 
encountered in the present study is illustrated in Pig. 1. The 
eluted fractions were evaporated to dryness under vacuum at 4-0°C. 
The residues were dissolved in a small quantity of hexane and ethyl 
acetate and stored in -jp-dram tapered screw cap vials in darkness 
at -20°C.
THIN-LAYER CHROMATOGRAPHY (TLO)
Preparation of chromatoplates
Glass plates (20 x 20 cm or 5 x 20 cm) were coated to a 
thickness of 0,25 mm with MN-Kieselgel G—HR (Macherey, Nagel 
and Co., Duren, Germapy) using a Quickfit (Quickfit and Quartz 
Ltd., Stone, Staffordshire) spreader, A slurry of $0 gras
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adsorbent with 45 ml distilled water was used. In the case 
of plates for preparative TIG the layer thickness was 0.5 mm.
One 20 x 20 cm chromatoplate of layer thickness 0,5 mm could 
accommodate a load of 40mg cf lipid without noticeable deterioration 
of separations. After spreading, plates were air dried for £ 
hour, activated at 120°C for 20 min, in a clean oven and stored 
in a dust-free cabinet until required.
Preparation of micro plates.
Micro plates used for the rapid monitoring of fractions 
from column chromatography were prepared as follows, A glass 
plate 20 x 100 cms was placed on the spreader. Microscope slides 
(7# 5 x 2,5 cm) were moistened and stuck firmly on the base 
plate. The layer was spread in the usual way; the thickness 
used was 0,25 mm.
Preparation of silica layers impregnated with silver nitrate.
Silver nitrate impregnated plates were prepared by the
243 141
methods of Claude and Morris,, An aqueous silver nitrate
solution of appropriate concentration is used instead of water 
to prepare the adsorbent slurry. In the separation of fatty 
acid esters by use of silver ion impregnated layers, the level 
of impregnation used was 12$ (w/w), Separation of sterol and
stanol trifluoroacetates was best effected on silica gel contain­
ing 25$ (Vw) silver nitrate. After spreading, the plates were 
air-dried for 15 min# in darkness, and activated at 120°C for 
20 mir»t The activated plates were stored in a dry, light-tight 
cabinet wrapped in aluminium foil to prevent deterioration which 
occurs when such chromatoplates are exposed to light or atmospheric 
moisture.
k9
Methods of analytical TLQ.
Analytical chromatograms were developed in Shandon 
tanks (Shandon Scientific Co. Ltd., London)
lined with sheets of filter paper to assist atmosphere saturation, 
and chromatograms were developed through a distance of 15 cm. 
from origin to solvent front* Solutions of sample were 
prepared in volatile solvents such as hexane, chloroform, di­
ethyl ether or ethyl acetate, and were applied to the chromato­
gram ty means of a Hamilton 10y/l syringe. For most samples 
loads of between 10-30jjg were applied, resulting in symmetrical 
and easily detectable spots. In general spots were detected by 
spraying with a solution of 5$ (w/v) eerie sulphate in 10$ 
sulphuric acid. This was found to be an excellent general 
purpose reagent, of particular value, in view of the colour 
reactions produced, in the detection of sterols and sterol esters. 
After spraying, the chromatograms were heated in an oven at 150°C, 
for approximately one minute, which appeared to be the optimum 
time for spot colour development. If chromatograms are subjected 
to prolonged heating the spots turn black or brown, and the 
important diagnostic value of colour reactions is lost. Reagents 
used for the detection of specific types of compound or functional 
groups are given belows
2,4-iinitrophenylfrydrazine for the detection of free aldehyde and 
keto groups - 0.5$ (yV) 2,4-dinitrophenylbydrazine in ethanol 
(1000 ml) plus 10 ml concentrated hydrochloric acid.
Reaction: yellow or orange spots without heating.
Saturated aqueous potassium iodide solution for the detection of 
hydroperoxides.
Reaction: yellow spot without heating.
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Saturated sodium periodate in 1C$ sulphuric acid: for the
detection of saturated and unsaturated fatty acid mettyl 
esters.
Reaction: saturated fatty acid esters give light brown spots,
unsaturated esters give dark brown spots. The 
chromatogram was heated at 150^0 for 20 min. after 
spraying.
Methods of preparative TLC
Solutions of samples were applied to preparative
chromatograms using a Hamilton syringe of 50JJ.1 capacity. Where
large quantities of material were available for TLC, micro
applicators of 10 or 50jjlI capacity were used (Applied Science
Laboratories Inc.) These applicators enable bands to be
applied evenly and very rapidly. However, some spillage was
invariably found to occur, and in quantitative work, or where
only small quantities of material were available, a Hamilton
syringe was preferred.
Material on developed preparative chromatograms were
located by brief exposure to iodine vapour* Although compounds'
containing polyunsaturated fatty acids are not altered by 
244this treatment, considerable losses of such compounds are
encountered when plates bearing them remain exposed to air and
245,2^6
iodine for more than a few minutes. Bands were therefore
eluted immediately after detection by this method. The use of 
silica gel with an added fluorescent material was found to be a 
very useful alternative to iodine vapour as a detecting agent.
The material used was Kieselgel -^254 (E, Merck, Darmstadt, 
Germaiy). Bands were located on chromatograms by their quenching 
of the fluorescence of the modified layer when viewed under an
51
2.6*
2.6.1,
ultraviolet lamp. Substances which could not be detected by 
either of these methods were located by comparison of the 
preparative chromatogram with a destructively sprayed analytical 
chromatogram of identical composition and degree of activity.
The efficiency of recovery of sample after preparative TLC 
is dependent upon the nature of the material adsorbed on the 
plate surface, and the type of solvent used for elution. The 
use of a mixture of chloroform:methanol (9:1 v/v) was found to 
give satisfactory recoveries (90-98$) of less polar lipids such 
as sterol esters, triglyceride and cholesterol. However, this 
method was not satisfactory for di- and tri-hydroxy sterols, or 
aromatic type compounds such as the estrogens. In such cases 
the silica was first deactivated with water, and the desorbed 
sterol was extracted with ether or etlyl acetate. If used 
with care this method yielded quantitative recoveries*
GAS LIQUID CHROMATOGRAPHY (GLO)
General methods
GLC was performed on a pye series 104 chromatograph fitted 
with two flame ionisation detectors. Glass coltrans of 5* suad 
10* lengths and inside diameter 3*5 nm were used, and were treated 
with a 5$ solution of dimethyldichlorosilane in toluene prior to 
use. The column packings used, with the appropriate supports 
and sources of supply are listed below*
1. 1$ SB-30 (methyl siloxane polymer) on 100-120 mesh Gas-Chrom Q.
2. 1$ JXR (methyl siloxane polymer) on 100-120 mesh Gas-Chrom Q.
3. 1$ QF-1 (fluoroalkylsiloxane polymer) on 100-120 mesh Gas- 
Chrom Q.
4. 3$ EGSS-X ( ethylene glycol succinate/methyl siloxane polymer) 
on 100-120 mesh Gas Chrom Q.
5. 1$ GV-17 (phenyl methyl siloxane polymer (50$ phenyl)) on
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80-100 mesh Chromosorb G HP*
6* 10$ FEQA (Poly ethyleneglycol adipate) on silanised Gras—
Chrom P* 80-100 mesh*
Column packings 1-4 were obtained ready made and pre-tested 
from Applied Science Laboratories Inc* Packing number 5 was 
obtained ready made from Supelco Inc*, Bellefonte, Pennsylvania, 
U.S.A. The 10$ poly ethyleneglycol adipate (PEGA) packing was 
obtained from Miss J*S* Young, M.R.C. Blood Pressure Research 
Unit, Western Infirmary, Glasgow, GX2 8QQ.
Samples generally 1-3 mg/ml were injected as hexane or 
ethyl acetate solutions using a Hamilton syringe. The volume 
of solution injected ranged from 0.2 - 5y^l. T*5® carrier gas 
used was oxygen-free nitrogen at a flow rate of 40 ml/nmu, and 
the injection port heaters were maintained at temperatures 
between 20° and 50° higher than that of the analyser oven.
2.6.2. Use of GLC for the quantitative determination of sterols and 
hvdroxy acids in extracts of arterial tissue.
Determination of hydroxy octadecadienoic acids:
Patty acid fractions (10-700yUg), obtained by hydrolysis 
of sterol esters were methylated and trimethylsilylated as 
described (ppp. 56-57). Quantification of hydroxy fatty acid 
methyl esters IMS ethers was performed using an external standard 
of methyl ricinoleate TMS ether. The column used was 10' long 
and was packed with 10$ poly ethyleneglycol adipate on 80-100 
mesh "silanised" Gas Ohrom P. The column temperature was 180°0.
Known quantities of methyl ricinoleate TMS ether were 
examined by GLC and a graph was drawn of the detector response 
(in terms of peak area) against the quantity of standard injected. 
Peak areas were calculated as the height of a peak times its
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FIGr. 2* Gas chromatographic estimation of hydroxy fatty acid 
esterss calibration graph relating detector response 
(in terms of peak area) against quantity injected for 
a reference sample of methyl ricinoleate TMS ether.
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width at half height* The graph (Fig* 2 ) showed good linearity 
over the range examined (0.2yUg-4*2yUg). The suitability of 
this standard for the analyses of tydroxy octadeoadienoic acid 
derivatives was determined by examination of known quantities 
of methyl 9-hydroxy-1O-trans. 12-trans-octadecadienoate (f- di- 
morphecolate) TMS ether, and comparison of the quantities 
injected with those calculated from the calibration graph* The 
acid derivatives were examined over a range of quantities, and the 
mean of two values of the detector response at each quantity 
injected was used to calculate the required quantities from the 
calibration graph* Results are presented in Table 4 , and 
demonstrate that over a range of 1-3*6yUg, methyl ricinoleate TMS 
ether may be successfully used as an external standard without 
the application of a correction factor. Aliquots of fractions 
containing hydroxy octadeoadienoic acid derivatives were similarly 
examined by GLC. By use of the calibration graph, the quantity 
of material injected and thus the total quantity in the sample 
could be estimated. The standard methyl ricinoleate TMS ether 
was prepared from the methyl ester shortly before analysis*
The calibration graph was drawn immediately before injection of 
the sample to be determined*
Determination of sterols:
Quantitative determination of sterols utilised a very 
similar technique. For the determination of 26-hydroxycholesterol, 
the reference standard used was the corresponding bis TMS ether.
The column used was SB—30 on Gas Chrom Q and analyses were
performed at 240°C. Cholestanol was determined as its trifluoro- 
acetate on a column packed with QF-1 on Gas Chrom Q at 200^0,
3k
2.7. GAS CHRCMATOGRAPHT-MASS SPECTROMETRY (GC-MS)
Mass spectra were obtained using an LKB model 9000 gas 
chromatograph-mass spectrometer (LKB-Produkter AB, Stockholm, 
Sweden). This instrument is a single focusing mass spectrometer 
fitted with a 60° sector, 20 cm radius magnetic analyser and 
a sweep generator for fast scanning of spectra. A two-stage 
jet separator of the Becker-Ryhage -type enables removal of 99$ 
to 99.5$ of the carrier gas (helium) and retention of 50$-75$ 
of the sample eluted from the gas chromatographic column. The 
instrument was fitted with a "mass marker" to facilitate counting 
of spectra. Spectra of samples reported in the present study 
were obtained using a carrier gas flow rate of 25-35 ml/min., 
electron energies of 70 eV - 22.5 eV, and an accelerating voltage 
of 2.5 - 3.0 Kv. The temperature of both the ion source and 
the molecular separator was 275°C.
Prior to analysis by GC-MS samples were examined on a 
Tye 101*. chromatograph. Retention times and retention index 
values were determined, and the quantity of the sample to be 
analysed was determined by comparison with an external standard.
A background mass spectrum was obtained in the absence of sample 
and under identical conditions to correct for spectral peaks due 
to gas chromatographic column packing.
2.8. CHEMICAL TECHNIQUES 
Hydrolysis of sterol esters
To a solution of ester in the minimum quantity of benzene, 
was added an ethanolic solution of potassium hydroxide consisting 
of 6 ml of 33$ aqueous potassium hydroxide in 50 ml absolute 
ethanol. The mixture was heated at 40^0 for 1 hour. Ether 
extraction yielded sterol fractions and the aqueous layer was
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acidified with dilute hydrochloric acid. Re-extraction with 
ether yielded fatty acids.
Reduction of sterol esters with lithium flltrnnrntyrn hydride.
The ester to be reduced was dissolved in a small quantity 
of sodium—dried ether, A solution of lithium aluminium iydride 
in dry ether was added, and the mixture was heated at 60°C for 
15 min. in a sealed tube. Excess reagent was removed by the 
cautious addition of dry ethyl acetate, more ether was added and 
the organic solution was washed with an equivalent quantity of 
water. Products were recovered from the separated ethereal 
solution.
Reduction of esters with lithium aluminium deuteride.
The method used was essentially that used for lithium 
aluminium hydride reduction except that lithium aluminium 
deuteride (LiAlD^, Isotopic purity 99 Atonf^ D, GIB A Ltd,) was 
used.
Conversion of steroid and aliphatic hydroperoxides and ketones 
to the corresponding alcohols,
A solution of hydroperoxy or keto compound in the minimum 
quantity of benzene was added to an excess of a solution of 
methanolic sodium borohydride. The reaction mixture was stirred 
for 30 min, at room temperature. Methanol was removed under 
vacuum, and the residue was dissolved in ether and washed several 
times with an equal quantity of water. After drying the derived 
alcohol was recovered from the ethereal solution.
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Hydrogenation of olefinic fatty acids and their derivatives.
Hydrogenation was performed in a microhydrogenation 
apparatus, using Pt02 as catalyst. 1-2 mg of catalyst was added 
to a small conical flask containing 3 nil methanol and a am* 11 
magnetic stirring rod. The flask was fitted to the hydrogenation 
apparatus and hydrogen was passed into the reaction flask for £ 
hour. The sample (5-500yUg) was introduced into the reaction 
flask as a chloroform solution, via a rubber septum fitted to 
the apparatus. The hydrogen flow was stopped and the solution 
was stirred for two hours at room temperature. The apparatus 
was flushed with nitrogen, the methanol solution was filtered, 
evaporated to dryness and the products taken up in ethyl acetate.
Oxidation of hydroxyoctadecadlenoic acid methyl esters.
Oxidations were carried out overnight at room temperature 
using suitable quantities of a mixture prepared from chromium 
trioxide (200 mg) and diy pyridine (6 ml). After the reaction 
the pyridine was removed in a stream of nitrogen, water was 
added, and the products were extracted with ethyl acetate.
Metfaylation of fatty acids.
Diazomethane was prepared from Bis-(N-methyl-l£-nitroso)
2L1
terephthalamide. Patty acids were methylated with a freshly
prepared solution of diazomethane in ether at room temperature.
The reagent was added until the yellow colour of diazomethane 
persisted* Excess reagBnt was removed in a stream of nitrogen 
and the methyl esters were dissolved in ethyl acetate.
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Acetylation of sterols.
The sterol (approximately 100jjig) was dissolved in dry- 
redistilled pyridine (20^41). An excess of dry acetic anhydride 
(10-20^x1) was added, and the reaction mixture was heated at 80*^ 0 
for 3 min. Excess solvent and reagent were blown away in a 
stream of nitrogen. The residue was dissolved in ethyl acetate 
(5 ml) and washed with 3 x 5 ml portions of water. Sterol 
acetates were recovered from the dried ethyl acetate solution.
Formation of sterol trifluoroacetates.
The sterol (3mg - 10yx g) was dissolved in the minimum quantity 
of chloroform and an excess (approximately 20y*l) of redistilled 
trifluoroacetic anhydride was added. After 10 min. at kQ°C the 
excess reagent was blown away with nitrogen and the residual 
trifluoroacetates were dissolved in hexane. Trifluoroacetates 
prepared in this way showed no decomposition if stored as hexane 
solutions in tightly capped vials at -20^0.
Formation of trimetbylsilyl (TMS) ethers of sterols and other 
alcohols.
The alcohol to be trimethylsilylated (4mg - lOyWg) was 
dissolved in the minimum quantity of dried redistilled pyridine. 
Hexamethyldisilazane (approximately 30jtl) and trimethyl- 
chlorosilane (approximately 5J^) were added, and the reaction 
mixture was heated at 80°C for a few minutes. Excess reagents 
were blown off in a stream of nitrogen and the products were 
dissolved in ethyl acetate. For short term storage of TMS 
ethers removal of insoluble material by filtration was found to 
be adequate; otherwise the ethyl acetate solution was washed with 
water, dried and stored in darkness at -20°C*
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Preparation of deuterium-labelled trimethylsilyl ethers.
The alcohol (l0-10Cytg) was dissolved in an excess (~5ytl) 
of dwj g-bis-C trimethvlsilvl^ -acetamide (Merck, Sharp and Dohme of 
Canada, Ltd.) The reaction mixture was heated at 80°C for two 
minutes, Excess reagent was removed in a stream of nitrogen, 
and the products were dissolved in ethyl acetate. Samples were 
stored as ethyl acetate solutions in darkness at -20°C.
Preparation of 0-Methyl Oximes.
The ketone (10-100jig) was dissolved in pyridine (^10yt*l) 
and approximately 2 0 of a saturated solution of 0-methyl 
hydroxylamine hydrochloride in pyridine was added. The mixture 
was heated at 80°C for 3—4. man. Excess solvent was removed 
in a stream of nitrogen, the residue was washed with water and 
the oximes were extracted into ethyl acetate.
Section 5 RESULTS
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3.1. STUDIES OP OXIDATION PRODUCTS FRCM OHQLESTEKTL LINOLEATE
3.1.1# Introduction
The mono hydroperoxides obtained by oxidation of methyl
2A8-250 pC'i —oct
linoleate have been extensively studied. Bergstrom ~
demonstrated that autoxidation of methyl linoleate produces 
conjugated dienoates with hydroperoxide groups either at 
C(^) or 0^^^ of the fatty acid chain. Subsequent investigations 
have shown that 30fo of the autoxidation products of methyl 
linoleate consist initially of approximately equal quantities 
of the 9”hydroperoxy-10-trans. 12-cis-octadecadienoate and the 
isomeric 13-hydroperoxy-9-cis, 11 -trans-ootadeoadienoate. 
Appreciable quantities of the corresponding trana.trans isomers
have also been detected after continued autoxidation at room
25A--2 56
temperature.
Chloropby 11-phot o s ens it is e d oxidation of methyl linoleate 
has been shown to produce considerable quantities of non­
conjugated hydroperoxides which were initially thought to be
257 258
11-hydroperosy-octadecadienoates. 9 More recent work, 
however, has identified the non-canjugated products as 10-
hydroperoxy-8-trans, 12-eis, and 12-hvdroperoxy-9-cis. 13-trans-
259,260
octadecadienoates. Recent work on the minor lipids of
human atherosclerotic tissue has established the presence of
a group of cholesterol esters in which the acid moieties are
1 2f) 1 27
hydroxy-octadecadienoat es. 9 Analogous hydroperoxides
of cholesteiyl linoleate (possible precursors of the bydroxy- 
esters) have also been identified in extracts from advanced 
aortal lesions, and in order to gain more information about 
the nature and origin of these compounds a study of the 
oxidation of cholesteiyl linoleate was undertaken.
SOLVENT FRONT
CHOL LINOLEATE 
(Rf 0-82) •
HYDROPEROXIDES 
( Rf 0-56)
ORIGIN
FIG-. 3® Analytical thin-layer chromatogram of autoxidised 
cholesteryl linoleate. Mobile phase: bensenc:
ethyl acetate (20:1 v/v).
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3*1*2* Preparation and characterisation of the hydroperoxides produced 
by autoxidation of cholesteiyl linoleate,
A thin film of cholesteiyl linoleate (115 mg) was rotated
in a flask open to the atmosphere for 5 days at room temperature*
Examination of the reaction mixture by TLC (mobile phase:
benzene: ethyl acetate, 20:1 v/v) showed the presence, at R^ s
0*56, of material more polar than cholesteiyl linoleate (Fig. 3),
This material coloured yellow when sprayed with potassium
iodide solution* The hydroperoxides were separated from
substrate by preparative TLC to yield 21 mg of a colourless oil.
It was subsequently found that exposure of cholesteiyl linoleate
to a jet of oxygen enabled yields of 40-5Q$ to be obtained after
4 hours.
Infrared spectroscopy of the hydroperoxide showed
1 mml
absorptions at 3410cm" (^0-H) and 840cm" (^  0-0), Ultra­
violet spectrometry of the material showed an absorption at
WAAtT
- ■ 232 nm (£ _ a 22,000). characteristic of a conjugated*1 max max 9 *
A *  2 6 1diene.
Treatment of the hydroperoxides with hexametbyldisilazane 
produced material, which on TLC examination migrated to 0*84 
(mobile phase: beiuane: ethyl acetate, 20:1 v/v) and showed
signs of considerable decomposition*
251.262
In view of the instability of the hydroperoxides, full
characterisation of these compounds entailed the formation of 
stable derivatives which could be conveniently examined by GLC 
and GC-MS. Reduction of the iydroperoxy-esters with sodium 
borohydride yielded the corresponding bydroxy-esters.
Examination of the products by TLC (mobile phase: benzene:
ethyl acetate, 20:1 v/v) showed a major spot at Rf 0,43 (red- 
brown) flanked by two lesser spots with R^’s of 0*47 end 0*40
%
Colour reaction Colour reaction
Benzene/ 
Etlyl Acetate 
20:1 v/v
with Ceric 
Sulphate 
Reagent
with Potassium 
Iodide Reagent
Cholesteryl
linoleate 0.76 Maroon None
Cholesteryl
linoleate
hydroperoxides 0.56 Red-brown Yellow
Hydroperoxy- 
esters from 
aortal extract 0.54 Red-brown Yellow
Cholesteryl
linoleate hydro­
peroxides after 
horohydride 
reduction
0.47
0.43
0.40
Blue
Red-brown
Blue
| None
j
Hydroxy-esters 
from aortal 
extract
0.52
0.47
0.41
Blue
Red-brown
Blue
| None
Aortal hydro- 
peroxy- esters 
after
horohydride
reduction
0.47
0.42
0.38
Blue
Red-brown
Blue
| None
TABLE 5* Comparison of the thin-layer chromatographic
properties of reference and isolated hydroxy- and 
hydroperoxy-esters of cholesteryl linoleate.
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which coloured blue when sprayed with eerie sulphate reagent.
This chromatogram bore a strong resemblance to those of hydroxy— 
esters of cholesterol previously isolated from extracts of 
advanced aortal lesions (Table 5). Alkaline hydrolysis of 
the reduced material yielded acidic and neutral fractions. 
Examination of the latter by TLC (mobile phase: chloroform:
ethyl acetate, 3 s 1 V v) showed two spots, identical in Rf> and 
colour reaction to cholesterol (R^ 0.6l) and either or both 
of the epimeric 7-hydroxychole sterols (Rf 0.20). The two 
bands were separated by preparative TLC, and the isolated 
sterols were trimethyls ilylated and examined by GLC. 
Chromatographic results are presented in Table 6. The 7- 
hydroaycholesterol fraction contained both the 7C* and Ip epimers. 
Analysis by QSJC indicated a four-fold excess of the 7<* epimer.
The acidic fraction from hydrolysis was methylated, 
trimethylsilylated and examined by GLC. Four peaks were 
observed, in the gas chromatogram. The retention index values 
of the components in the mixture were compared with those of 
the corresponding derivatives of available acids, and results 
are presented in Table 7. The mass spectra of the acid methyl 
ester trimethylsilyl (IMS) ethers derived from the hydroperoxides 
and those of the appropriate derivatives of the reference acids 
showed considerable similarities. The major ions in the mass 
spectra of all these ccmpounds are given in Table 7# The mass 
spectrum of the most mobile peak on GLC was not obtained.
However, the chromatographic data presented in Table 7 isiply 
that this substance is methyl linoleate, and it was estimated 
to account for approximately of the total acids in the 
fraction. The mass spectra indicate that the hydroxy—acids 
derived from cholesteiyl linoleate hydroperoxide are very
1M
I
SOLVENT FRONT
Rf 0  52
0 - 4 0
0 - 3 5
0-20
ORIGIN
FIG-. 4* Analytical thin-layer chromatogram of the products from 
LiAlH^ reduction of cholestexyl linoleate hydroperoxides 
(Lane l), and reference samples of cholesterol (Lane 2), 
-hydroxycholesterol and octadeoadiene-1,9-diol (Lane 3) 
Mobile phase: chloroform:ethyl acetate (3:1 v/v).
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1C- S INDICATED BY AN ASTERISK ARE REPRESENTED AT J/foth THEIR TRUE RELATIVE INTENSITIES
FIG-. Comparison of the mass spectrum of the 7”hydroxycholesterol 
bis TMS ethers derived from autoxidised cholesteryl 
linoleate with that of authentic T^-hydroaycholesterol-bis- 
TMS etherft
TLC BAND 2 T LC  BAND 3
9 J1 -O C T A D E C A D IE N E -1J3 -  
— DIOLS- BIS —TMS ETHERS
10 12-OCTADECADIENE-1,9- 
— DIOLS- B IS - TMS ETHERS
2390
2350 2350
minutesmi nutes
FIG-, 6„ Gas-liquid chromatogram of octadecadiene-1,13- and 1,9-cliol- 
bia TMS ethers after separation of the diols by preparative
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263-265
similar to those found in seed oils. Although gas-liquid 
chromatographic and mass spectral results indicate that the 
acids derived from hydroperoxide are l^rdroxy-octadecadienoic 
acids it is extremely difficult to distinguish between the 9- 
and the 13**hydroxy derivatives, the mass spectra being very 
similar. It was desirable that derivatives of the hydroperoxy- 
esters with more characteristic mass spectral properties be 
prepared to enable full characterisation of both synthetic 
hydroperoxides and those occurring in aortal extracts.
Reduction of the hydroperoxides of methyl linoleate with
215
lithium aluminium hydride, and subsequent trimethylsilylation, 
has been shown to produce derivatives which can be readily 
distinguished by mass spectrometric methods. In accordance 
with these results a sample of cholesterol linoleate hydro­
peroxides was reduced with lithium aluminium hydride as 
described on Page 53 > and examined by TLC (mobile phase: 
chloroform: ethyl acetate, 3:1 v/v). Four bands were observed 
(Fig. 4) and were separated by preparative TIC. The most 
mobile band (1) at 0*52 corresponded to cholesterol on TIC, 
both as the free sterol, and as the TMS ether (B^ a 0.45, 
mobile phase: hexane:benzene, 2:1 v/v). GIC indicated the 
presence of cholesterol and some linoleyl alcohol (Table 8).
The least mobile band (4) (Rf 0.20) was similarly identified 
as a mixture of the epimerio 7-hydroxyc hole sterols; in this
case the identities were confirmed by mass spectral analysis 
of the TMS ethers. Mass spectra of the 7-trimethylsilylosy 
cholesterol epimers were identical to those of reference 
samples (Fig. 5)* Bands (2) (R^ 0.40) and (3) (Rf 0.35) were 
separately extracted from silica in chloroform and trimethyl* 
silylated. GLC of band (2) (Fig. 6) revealed the presence of
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!$
7* Mass spectra of the octadecadlene~l,13-3-lol~bi3 TMS ethers 
derived from autoxidised cholesteryl linoleate.
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FIG* 8» Proposed rearrangement explaining the occurrence of an ion with 
n/e s 225 in the mass spectra of 9« ll~octadeca&iene~l» 13 diol- 
bis TMS ethers*
.-------->355
h i
i Si 
ll V ■0 x
I'.. -..tCH^CH^CH—  CH= CH —  CH--CH-(CH2yaSi(CH3^
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Jill „lli litli 111 I,L, I.il I li mil.. .1 ..I..
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r-------- >373
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FIG* 9. Comparison of the mass spectra of the TMS and g per&euteratad 
TB.TS ethers of 9~tran3s 11-trans octadec&dieno-l,13-diol derived 
from autoxidised cholesteryl linoleate*
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two major peaks with retention indices on \% SB-30 at 180°C,
of 2350 and 2420. The mass spectra of both compounds are
reproduced in Fig. 7, and are consistent with those of a pair
of 9,11 -octadecadiene-1,13-diol bis-TMS ethers. Both mass
spectra are identical and show the expected molecular ion at
n/e 426. The major diagnostic ion is at n/e 355. This
represents cleavage of the carbon-carbon bond between 
. 215,206^,
and Cleavage is less probable at a position adjacent
to the conjugated diene system and a much smaller ion is
, 205,207
observed at n/e a 173* The ion at 225 probably
arises via a qyclic rearrangement of the type shown in Fig. 8#
Confirmation of the identity of the major ions in the mass;
spectra of the octadecadiene-1,13 diols bis TMS ethers was
obtained by comparison with the mass spectra of the perdeuterated
TMS ethers (Fig. 9). In the deuterium labelled molecule
the molecular weight has risen by 18 mass units to 1*44.
Similarly the ion at n/e 355 in the non-labelled molecule
increases by 18 mass units to n/e 373* This demonstrates the
presence of two trimethylsilylosy groups in the original fragment.
The ion at n/e. 225 increases by 9 mass units to 334 in the
labelled molecule. Thus this fragment contains one trimetlyl-
silylozy group, in agreement with the fragmentation proposed
in Fig, 8. The nature of the ion at n/e 130 in the non-labelled
TMS ether can be inferred from data for the labelled derivatives.
The rise in mass of this ion to 5/e 139 reveals the presence
of one trimethylsilyloay group and indicates a molecular
formula C^ Htj 0TMS+*. The mechanism ty which this ion is foxmed
will be discussed later. The identity of the octadecadiene-
diols in band (2) was confirmed by hydrogenation using PtO^
methanol (as described on Page 56), and examination of the
TLC
GLC Retention data of 
diol TMS ethers
REFERENCE DIOLS
Rf
Chloroform: 
Etl^ yl Acetate 
(3:1 v/v)
1 fo SE-30 
180°C
10$ FEGA 
188°C
3$ EG-SSX 
150°C
1O-trans,12-cis- 
1,9 diol 0.1*j6 2350 2415 2485
1O-trans,12-trans- 
1,9 diol 0.48 2390 2485 2530
9-cis,11-trans- 
1,13 diol 0.53 2350 2420 2470
9-trans, 11-trans- 
1,13 diol 0.53 2420
DIOLS FRCM 
AUTOXIDISED 
CHOLESTERYL 
LINOLEATE
BAND 2 0.55 23502420
2420
2555
2475
2545
BAND 3 0.49 23502390
2420
2485
2480
2530
TABLE 9. Chromatographic data for reference samples of octa-
decadienediols and for those derived from cholesteryl 
linoleate hydroperoxides prepared "by autoxidation0
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TMS ethers by GLC and mass-speotrometxy. GLC on 1$ SE-30 at 
180°C afforded a single peak with retention index of 2390.
The mass spectrum confirmed the molecular weight of 430. The 
expected cleavages adjacent to the secondary trime thylsilyloxy 
group yielded intense ions at n/e 173 and n/e 359, as shown 
below.
i ->359 (a)
i OTMS
CH3-(CH2)4^ H j ( CH2 ^ ° ™ S
(b) 173 <---------! +•
M= 4 3 0
With bis perdeuterated TMS ethers: It** a 2*48
(a) . 377
(b) = 182
These results indicate that band (2) contains a pair of isomeric 
9,11-octadecadiene-1,13-diols, The more mobile peak
= 2350) was found to have identical retention
1# SE-30
characteristics (Table 9) and mass spectrum to the corresponding
derivative prepared from authentic methyl 15-hydroxy~9-cis.11-
180°C
trans-octadecadienoate- The material of 1 ^  qe-30 = ^20 is 
regarded as the corresponding trans. trans-isomer, which is an 
expected component by analogy with previous work. This assign­
ment is supported by gas chromatographic correlations (Table 9)* 
It is thus concluded that the material in band (2) consists of 
a mixture of the 9-cis. 11-trans-and the 9-trans. 11 -trans- 
octadecadiene-1,13-diols.
4 10-IRBNS-12-£IS-0CTRDECRDIENE-1,9-DI0L-BIS TMS
1-2350
100 20 * 1
225
130
143
355
50 100 150 200 250 300 350 400
MRSS / CHARGE RATIO M/E
3 10—TRRNS— 12— TRflNS—OCTRDECRDIENE— 1. 3~DIOL—SIS TMS
I-2390
100 28.G
225
130
426
355
MASS / CHARGE RATIO M/E
10. Mass spectra of the octadec adiene-1p9"diol-bia TITS ethers 
derived from autoxidised cholesteryl linoleate.
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The octadecadiendiols present in hand (3) were identified 
by similar methods. In this case examination of the bis-TMS 
ethers by 0/3 (lf5 SE-30, 180°C) showed two peaks at I s 2350 and 
I a 2390 (Fig* 6). The mass spectra of both compounds are 
reproduced in Fig. 10. The spectra, which are essentially 
identical, show the expected molecular ion a t ^ e  s 426. The
base peak at n/je = 223, corresponds to a fragment formed by
2*15
cleavage of the bond between and Ians 5/®,
130 and 355 were observed but with much smaller relative 
abundances than for the 1,13-diol derivatives. The ion at m/e = 
355 almost certainly arises by means of the mechanism 
proposed in Fig. 8. Mass spectral examination of the perdeuterated 
TMS ethers gave the same results as for material in band (2). 
hydrogenation of material from band (3) and subsequent formation 
of the TMS ethers showed one peak on <2/3 at I ^ - J O  = 2375‘
Mass spectral analysis of this compound showed the expected 
increase of the molecular ion by 4 mass units to g/e = 430.
The diagnostic ions are in this case observed at n^e s 229 find 
o^e ss 303, and represent-cleavage of the bonds on both sidess 
of the secondary trimethylsilyloxy group as illustrated below:
i----- -*303
! OTMS
OTMS
2°/o
O
17 31
8 %>.
17 3
. O H■or, N |____ trans_____ cis , \
45 o/o. CH (CH JCH—C H = C H -C H = C H - (C H  )
4 trans trans
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7
CIS trans
45 o/o. CH C H j C H=C H -CH  =  CH
'4 trans trans
/ O H  
O O
CH-^CH j c - O R
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PIG-. 11* Nature and relative proportions of the primary hydroperoxides 
produced by autoxidation of cholesteryl linoleate.
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the identities of these ions were again confirmed by formation 
of the perdeuterated TMS ethers of the octadecanediols and 
subsequent mass spectral analysis. Comparison of gas chromato­
graphic and mass spectrometric data of the TMS ethers of the 
octadecadienediols from band (i), with those of reference 
compounds (Table 9) indicates that the components in band (3) 
are the cis,trans- and tran3.trans-1,9-ootadecadienediols: the
trans. trans derivative has the longer retention time.
The composition of the mixture of original hydroperoxy-esters 
is concluded to be as shown in Pig, 11,
The approximate relative quantities were determined by comparison 
of the peak areas in gas chromatograms. In the case of the 
octadecadienediols the ratio of cis,trans to trans.trans isomers 
varies according to the age of the hydroperoxide sample prior 
to analysis; larger quantities of the a11-trans isomers were 
formed with increasing age. However, the relative quantities 
cis.trans to trans.trans isomers in both the 1,9- and 1,13- 
diols produced by reduction of freshly prepared hydroperoxides 
were roughly 2:1 in both cases.
3.1.3. Preparation and characterisation of the mono hydroperoxides
of cholesteryl linoleate produced by methylene blue-sensitised 
photo oxygenation.
A solution of cholesteryl linoleate (500 mg) in chloroform 
(15 ml) with methylene blue (2 mg) as sensiti3er was placed in 
a small tapered tube. Oxygen was bubbled into the solution via 
a delivery tube with its outlet at the bottom of the reaction 
vessel. The reaction time was 2 hours, and the irradiation was 
provided by four 60 watt tungsten light bulbs positioned about 
2" from the reaction tube. Frequent additions of chloroform 
were made to compensate for that lost by evaporation. The
    ,-----
12
' m i n u t e s
TTT
PIG-. 12, Gag-liquid chromatogram cf the octadecadienediol bis
TMS ethers derived from hydroperoxides of cholesteryl 
linoleate prepared by photo-oxygenation. Peak 1 
consists of a mixture of non-conjugated octadecadiene- 
1,10- and 1,12-diol bis TMS ethers.
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reaction mixture was evaporated to dryness and the residue 
dissolved in a small quantity of hexane* Examination of the 
solution by TLC (mobile phase: benzene:ethyl acetate, 20:1 "v/v) 
showed two spots at Rf =- 0*78 and Rf » 0.34. The lower spot, 
when sprayed with aqueous potassium iodide, gave the colour 
characteristic of hydroperoxides* The mixture was chromato­
graphed on 100 g silicic acid. Cholesteryl linoleate was 
eluted in 15-25$ chloroform in hexane* Monohydroperoxides 
were eluted in 35-40$ chloroform in hexane, and smaller 
quantities of more polar compounds, also present in the mixture, 
were discarded* The quantity of cholesteryl linoleate recovered 
was 215 mg* The mono-hydroperoxides were further purified by 
preparative TLC (benzene: ethyl acetate, 20:1 v/v), and the yield 
was 197 mg*
The purified! hydroperoxides were characterised by reductive 
cleavage with lithium aluminium hydride as previously described, 
and the products were examined by TLC using a mobile phase of 
chloroform:ethyl acetate (3*1 v/v), The resultant chromatogram 
was almost identical to that produced by the corresponding 
products derived from autoxidised cholesteryl linoleate* Bands 
were observed at R^ = 0*65 (cholesterol), R^ 0*45-0,58 
(octadecadienediols), and 0.20 (epimeric 7-bydroxycholesterols)* 
Material from the central band was purified by preparative TLC, 
and a small quantity was trimethylsilylated and examined by GLC 
(1 $ SE-30, 180°C)* The chromatogram (reproduced in Pig. 12), 
showed four peaks, and retention indices are given below:
Mass spectrcmetric analysis of the fraction showed Peak 2 to
Peak 1 
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if)
oo ^
o
o
o
| o—o o
o-
</>
o
o
o o
rd 0© *>
it k 
1 •HPd
0 rH
ra 0 0P. <0 U
a1 O !>> 0© P rQ d43 UM rd p0
$ 0P P<-d d •H
P o 0o *H 43
a »d Pw w0 •H Wu
1 >1 0 inrH o OTO o O p•ri 43 d'd _p! 0 rdCM cw 0
H d O P<r» 1?, dr“l P 0•H O wTJ s *H ©
£» P$ ft ft43 0 0
1 fH Oo XiH 0 ©ui—1 
1
»
0 0x; d<!> P p m
c d m© 0 43 V”•H rH Pfd O *Hd
0 .5
!s->- c343© rH Pfd ka H «p hw o
0
g m Po 0 N"\ dp CO ©Vi 03 ! £•«O 0
r~i
bO
0 O O ©!
U K\ 'Cld o t mp
X rd o vi•H 0 o o
s p  V? co 0COd C0 M SoVi w »d *HO
&
d
43 Hcd o H1 /—^ (0P o CMo p V «s0 o Ma* ,d e toW ft bu*H •rlto C5M ft ©© O Pd h J3 0Vi ♦ri cd
O
r<*\
in
te
ns
it
ie
s
69
consist of a mixture of a 9,11-octadecadiene-1,13 diol bis-TMS 
ether and a 10,12-octadecadiene-1,9 diol bis-TMS ether. GLC 
correlation indioated that these compounds were cis.trans isomers 
(Table 9)* Similarly Peaks 3 and 4 were identified by GLC and 
GC-MS as being respectively 10-trans. 12-trans-octadecadione-1 >9 
diol, and 9-trans. 11 -trans-octadecadiene-1,13 diol bis-ffMS 
ethers. These four isomers have been identified in the 
corresponding TLC fraction from reduction products of the 
cholesteryl linoleate hydroperoxides prepared by autoxidation.
The major peak (Peak 1) in the chromatogram (Pig. 12) had not, 
however, been previously observed. Re-examination of the free 
octadecadienediol fraction on TLC revealed two bands at Rf = 0.45 
and 0.55 (mobile phase: chloroform:ethyl acetate, y, 1 v/v).
The upper portion of the more mobile band (Rf 0.57-0.60) was 
removed and a small quantity was trimethylsilylated and examined 
by GLC (1$ SE-30, 180°C). At least 95% of the material 
chromatographed was eluted with a retention index of 2330, thus 
corresponding to Peak 1 in Pig. 12* Mass spectral analysis of 
Peak 1 (Pig* 13) revealed a mixture of two previously unencountered 
diols.
The mass spectrum is consistent with that expected for a 
mixture of an octadecadiene-1,10 diol-bis-TMS ether, and an 
octadecadiene-1,12-diol bis-TMS ether. The molecular is, as 
expected, at n/e a 426, but is of much lower relative intensity 
than that found in spectra of the conjugated octadecadiene-1,9- 
and 1,13-diols. The major ions at n/e a 185 and n/e b  315 
represent cleavage adjacent to the secondary trim©thylsilylosy 
group as shown in Pig. 13* The lack of another ion representing 
-cleavage at the other side of this trimethylsilyloxy function 
suggests the presence of an olefinic bond adjacent to it.
Reference hydroxy stearic acid methyl 
esters, TMS ethers and octadecanediol
Retention Index
his TMS ethers.
% SE-30 
180°C
10<fo EEG-A 
180°C
Methyl-9-trimethylsilyloxy stearate 2325 2625
Methyl-1O-trimethylsilyloxy stearate 2325 2625
Methyl-12-trimethylsilyloxy stearate 2335 2635
Methyl-13-trimethylsilyloxy stearate 2335 2640
0ctadecane-1,9“diol his TMS 2375 2425
0ctadecane-1,10-diol bis TMS 2375 2420
0ctadecane-1,12-diol his TMS 2390 2425
0ctadecane-1,13“<3.iol bis TMS 2390 2420
Corresponding derivatives from photo­
oxygenated cholesteryl linoleate
Hydroxy acid methyl esters TMS ethers ( 2325 
( 2340
2625
2635
Octadecanediol his TMS ethers ( 2380 
( 2395
2420
TABLE 10. Comparison of the gas chromatographic retention data 
of reference saturated hydroxy acid ester TMS ethers 
and diol his TMS ethers with those of the corresponding 
derivatives from photo-oxygenated cholesteryl linoleate.
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(This phenomenon has been observed in the mass spectra of 
hydroxyoctadecenoic aoid methyl ester TMS ethers).206 It
is also noteworthy that the mass spectrum contains no ion at 
n/j© = 130, but that a prominent fragment exists at n/j5 = 129*
The significance of this observation will be considered later.
The implication (drawn from mass spectral data) that 
material in Peak 1 consists of non-conjugated octadecadienediols 
was supported by the absence of significant absorption at 233 nm. 
The proposed structures for the non-conjugated diols were 
substantiated by formation of perdeuterated TMS ethers and 
examination of mass spectra of the derivatives. In this case 
the molecular ion increased by 18 mass units from = 1+26 to 
st The diagnostic ions at n/ie = 185 (1,12-diol),
and n$/_e s 315 (1,10-diol) were found to increase to w/e a 1%. 
and g/e = 333 indicating the presence in the fragments of one 
and two trimethylsilyloxy groups respectively. The positions 
of the bydroperoxy groups in esters prepared from photo-oxygenated 
cholesteryl linoleate were verified in the following way:
A sample of purified (TLC) hydroperoxy-esters was reduced 
in sodium borohydridq/methanol solution. Alkaline hydrolysis 
yielded a hydroxy-acid fraction which was methylated with 
diazomethane, and hydrogenated as described on Page 56 • A 
portion of the saturated hydroxyoctadecanoates was reduced with 
lithium aluminium hydride and both hydroxy—acid esters and 
octadecanediols were trimethylsilylated and examined by GLC and 
GC-MS. GLC retention indices of these derivatives are shown in 
Table 10. Two peaks were observed in the chromatogram of the 
octadecanediol bis-TMS ethers (ifo SE-30, 180°C). The more 
mobile (i a= 2380) had a mass spectrum consistent with that
of a mixture of an ootadecane—1 f 9—diol bis-TMS ether and an
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PIG-, 15. Principal fragmentations giving rise to diagnostic ions 
in the mass spectra of hydroxy methyl stearate TMS 
ethers derived from photo-oxygenated cholesteryl 
linoleate.
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octadecane-1,1O-diol bis—TMS ether. The major ions can be 
explained by ©(-cleavage at both sides of the secondary trimethyl- 
silyloxy function. The mass spectra of these compounds, with 
total ion current trace are shown in Fig. 14. Similarly, the 
constituents of the second peak in the gas chromatogram (I = 2395) 
are identified as a mixture of an octadecane-1,12- and an 
octadecane-1,13~diol bis-TMS ether. Examination of the TMS 
ethers of the methyl hydroxyoctadecanoates by GLC (1$ SE-30,
180°C) revealed two peaks (Table 10). Mass spectrometry of 
these compounds indicated the presence of four isomeric tri- 
me thy Is ily loxy acid methyl esters. Peak 1 (I as 2325) showed 
ions at g/e = 386 (if**), n/e. = 229, and n/e^  = 259, which indicate 
the presence of the 9-trimethylsilyloxy derivative, and at n^e = 
215 and 273 characteristic of the 1O-trimethylsilylo^r isomer.
All the ions in the mass spectrum of peak 1 were also present
in a synthetic mixture of the 9- and 10-trimethylsilyloxy stearate
21 if
derived from methyl oleate.
Peak 2 (I a 2340) gave a mass spectrum showing diagnostic 
ions at B^e » 386 (M+*), ac/e = 173 and 3^5 (13-trimethylsilylo3y 
isomer), and at n/e = 187 and 301 (12-trimethylsilyloxy isomer). 
The bond cleavages producing the major ions in the four isomeric 
trimethylsilyloxy stearates are shown in Fig* 15* The results 
indicate that in contrast to the air or oxygen autoxidation of 
cholesteryl linoleate, the products of photosensitised oxidation 
contain considerable quantities of nan-conjugated hydroperoxy- 
esters of the type shown be lows
0 ' 0 H  c , O
C H C H CH— C H -C H -C H -C H = C H - 
4 2 2
//
COR
R represents CHOLESTERYL
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The products are very similar to those found to be formed by 
chlorophyll-photosensitised oxygenation of methyl linoleate.259,260
Although a study was not made of the reaction kinetics, 
the quantities of non—conjugated hydroperoxides appeared to 
increase as the reaction time was prolonged. Since the non- 
conjugated octadecadienediol bis-TMS ethers are readily 
separated from the conjugated isomers by GDC (Fig, 12), 
comparison of the peak areas probably gives a good guide to 
the relative quantities of conjugated and non-conjugated 
products in the reaction mixtures. Making this assumption, 
the proportion of non-conjugated esters in the reaction mixture 
increases from approximately 33$ after a reaction time of 2 hours 
to about 4-8$ in 4 hours. The significance of this observation 
and mechanistic evidence supporting the structures postulated 
above will be considered later,
3,1*4, Preparation and characterisation of ket0-esters of cholesterol.
It was observed that during purification of hydroperoxides 
of cholestexyl linoleate by preparative TLC on silica gel, small 
quantities of material were formed with a characteristic
absorption in the ultraviolet spectrum at 272 nm. Material
.. 231
with a similar absorption has also been observed by Bergstrom
26 2
and Christophersen during their respective studies on methyl 
linoleate hydroperoxides, and the absorption has been assigned 
to small quantities of a doubly conjugated ketone, presumably 
formed by dehydration of the hydroperoxides. During our work 
on polar esters of human atheroma similar absorptions have 
frequently been observed in fractions containing hydroperoxy— 
esters of cholesterol, and in order to gain information about 
these keto-esters, and to devise practical methods for their
Ce(S04) KI DNP
4.. .-tes, 4.' .i.
A
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PIG. l6. Thin-layer chromatograms illustrating the use of 
selective spray reagents to detect hydroperoxy- 
and keto-esters. Mobile phase: benzene:ethyl
acetate (20:1 v/v). For full explanation see 
text.
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separation from hydroperoxides, an authentic sample of keto 
esters ■was prepared.
50 mg of freshly prepared and purified hydroperoxides 
(from autoxidised cholesteryl linoleate) were heated in a 
sealed vial at 150°C for 20 min in the presence of dxy pyridine 
(200 yu1) and triethylamine (50 ^ 1). Solvent was blown off in 
a stream of nitrogen and the residue was dissolved in diethyl 
ether (200 jtl), and subjected to preparative TLC using a mobile 
phase of benzenes ethyl acetate (20:1 v/v). major band
at Rf a 0.57-0.64 was eluted from the silica and examined by 
analytical TLC using different reagents for visualisation of 
the spots. Pig. 16 illustrates three chromatograms (A, B and
0), To lane 1 of each chromatogram a sample of purified 
cholesteryl linoleate hydroperoxide has been applied; to lane 
2 a sample of the derived ketonic material, and to lane 3 a 
mixture of cholesterol and cholesteryl linoleate. After 
development in benzene;ethyl acetate (20:1 v/v), each plate 
was sprayed with a different reagent. Place A was sprayed 
with eerie sulphate. Plate B was sprayed with potassium iodide 
solution, and plate C was sprayed with 2,4-dinitropherylhydrazine 
reagent. Pig. 16 shows that plate A, when sprayed with the 
non-selective eerie sulphate solution reveals a spot in lane 1 
at s 0.54, corresponding to hydroperoxy-esters. Lane 2 
contains a spot at R^ = 0.59 (keto-esters), and lane 3 contains 
two spots at Rjf a 0.80 and 0.14 corresponding respectively to 
cholesteryl linoleate, and cholesterol. Plate B (sprayed with 
potassium iodide solution) shows only a spot in lane 1 at Rf* a 
0.54, and plate 0 (sprayed with dinitrophenylhydrazine reagent) 
shows a spot at a 0.59, in lane 2.
Thus these chromatograms indicate that hydroperoxy-and
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keto-esters can be distinguished during TLO analysis by spraying
with different test reagents# Such a distinction is valuable
in view of the very similar mobilities of the two types of
compound on TLO#
Ultraviolet spectroscopy of the derived ketones showed an
absorption of = 276, £ Et0H = 28,000. Pig. 17 compares
max ' max r
the U*V* spectra of purified samples of hydrops roxy-esters and 
keto-esters, and demonstrates another method of distinction 
between these compounds#
The structures of the derived keto-esters of cholesterol 
were determined by reduction with ethereal lithium aluminium 
deuteride (LiAlI^), and examination of the TMS ethers of the 
reduction products by GLO and GC-MS. Reduction of hydrops roxy- 
esters with this reagent produces four isomeric octadecadienediols 
which are labelled with a pair of deuterium atoms attached to 
the carbon atom containing the primary hydroxyl function#
The mass spectra of the derived trimethylsilyl ethers of these 
compounds: show a molecular ion at n/e a 428, and major ions at 
n/ja s 225 (indicative of 1,9-diols), and e/  e_ = 357, characteristic 
of the 1,13-diols.
In contrast, the octadecadienediols derived from keto- 
esters of cholesterol by treatment with LiAlD^, contain three 
deuterium atoms# Two of these are at -j ^ # The third
deuterium atom, however, is inserted at that carbon atom attached 
to the secondary hydroxyl fraotion (i#e# either or 13)) •
As a result the mass spectra of the TMS ethers of the diols 
produced from the different substrates are characteristically 
dissimilar#
The octadecadiene-1,9- and 1,13-diols from the reduced 
keto-esters were separately isolated by preparative TIC as
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previously described (Page 63). After trimetbylsilylation 
the products were examined by G-LC (1 % SE-30, 180°C). The 
fraction containing the 1,13-diol bis-TMS ethers contained two 
peaks with retention indices of 2350 and 2Zf15* These corres­
ponded respectively to the cis. trans-. and trans. trans- 
octadecadienediol derivatives and had identical mass spectra* 
Similarly, the fraction containing the 1,9-diol bis-TMS ethers 
showed two peaks at I s 2350 (trans,cis isomer) and at I a 2390 
(all-trans isomer), with identical mass spectra. The proportions 
of the cis. trans to trans. trans isomers were in both cases much 
less ( ^ 1:8, as estimated by comparison of peak areas) than 
those encountered in the octadecadienediol mixtures from reduction 
of bydroperoxy-esters (cf Pig. 6). This is likely due to 
isomerisation of the cis. trans forms to the more favoured all- 
trans compounds, during the thermally induced conversion of 
hydroper oxy-esters to keto-esters*
The mass spectra of the TMS ethers of the major constituents 
(all-trans) from fractions containing the 1,9- and 1,13- 
octadecadienediols are reproduced in Pig. 18.
The incorporation of three deuterium atoms into the 
molecules is indicated by the molecular ion at a k-2.9. The 
fragmentations are identical to those already observed in the 
products of both LiAlH^ and LiAlD^ reduction of by drope roxy- 
esters. However, the masses of the ions are different* Thus 
in the present case diagnostic ions are observed at g/e s 226 
and n/e = 358 which are respectively characteristic of the 1,9“ 
afid 1,13— octadecadienediol bis-TMS ethers. Each of these ions 
(M+* included) is, therefore, one mass unit greater than those 
observed in the corresponding derivatives from LiAlD^ reduction 
of hydroperoxy-esters, and the keto- and hydroperoxy-esters can
1)6 differentiated by mass spectral analysis of the deuterium 
labelled derivatives*
It has been demonstrated that bydroperoxy- and keto-esters 
of cholesterol may be distinguished by their spectral, mass 
spectral and thin-layer chromatographic properties* It seemed 
desirable, however, that mixtures of the two ester classes, 
such as those which occur in some arterial extracts, should be 
resolved, and the separated classes individually characterised. 
Both types of ester have very similar Rp values on TLC, and 
attention was given to chemical modification of one or other 
type, with the aim of separation of the modified species from 
the unreacted ester by preparative TLC*
The keto-esters were found to react with bydroxylamine 
hydrochloride in pyridine to produce oximes* The oximes, due 
to their increased polarity on TLC, can be separated from the 
hydroperoxides, but the reaction was found to require heating 
at 70°G to enable complete conversion of ketones to oximes, and 
when a mixture of bydroperoxy- and keto-esters were subjected 
to the required conditions, the bulk of the hydroperoxy-esters 
were converted to ketones and thence to oximes* This method 
was therefore obviously unsuitable*
Selective reduction of hydroperoxy-esters in the presence of 
keto-esters by reaction with stannous chloride*
Sodium borohydride in methanol reduces both hydroperoxy- 
and keto-esters to the corresponding alcohols. Hydroperoxides
of methyl oleate have, however, been reduced to the hydroxy
207
compounds by use of acidic stannous chloride solution. It
appeared likely that hydroperoxides of cholesteryl linoleate 
should react in a similar fashion, whereas the keto-esters should 
remain unaltered*
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To 15 ml of a solution of 0*1 N stannous chloride in 
hydrochloric acid, prepared according to Barnard and Hargrave 
was added a mixture of purified hydroperoxy-esters (7.2,. mg) 
and keto-esters (5.5 mg) in benzene (0.20 ml). Acetone (10 ml) 
was added to render the mixture homogeneous. The solution 
was stirred for 2 hours at room temperature, and the products 
were extracted into 3 x 10 ml portions of diethyl ether. The 
ethereal solution was washed with 60 ml water, dried, and the 
products examined by TLG. The chromatogram is shown in Pig. 19* 
Lanes 1 and 2 respectively contain reference samples of keto- 
and hydroperoxy-esters. Lane 3 contains a sample of the mixture 
prior to reduction, and Lane if shows the reduction products.
The mixture of esters on the developed chromatograms were sprayed 
with 2,if-dinitrophenyliydrazine and potassium iodide spray 
reagents. Material in Lane 3 (prior to reduction) gave a 
positive result with both reagents. The mixture of esters in 
Lane if, however, gave no reaction with potassium iodide, but the 
upper spots at Rf a o-4-6 gave a positive result with 2, if-dinitro- 
pheiylhydrazine solution. The mobility of the lower band im 
Lane if was identical to that of a mixture of hydroxy-esters of 
cholesterol. The keto- and hydroxy-esters were separated by 
preparative TLC (mobile phases benzene:ethyl acetate, 20:1 y/v) • 
The quantities recovered were respectively 5*3 mg and 5*8 mg.
The almost quantitative conversion of the hydroperoxides and 
retention of the ketones were confirmed by ultraviolet spectrometry. 
The reduction was repeated using 200 ytg of a mixture of keto- and 
hydroperoxy-esters, and the same efficiency of the selective 
reduction on the smaller scale was confirmed. This method should 
be applicable to the characterisation of bydroperoxy- and keto- 
esters present in aortal tissue extracts.
SOLVENT FRONT
TRIGLYCERIDES
HYDROPEROXY-& 
KETO- ESTERS
HYDROXY-ESTERS
CHOLESTEROL
ORIGIN
PIG-. 20. Analytical thin-layer chromatogram of the fractions of an 
arterial lipid extract containing polar sterol esters. 
Mobile phases benzene:ethyl acetate (20:1 v/v).
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PIG-, 22. Thin-layer chromatograms of fractions containing hydroxy- 
and hydroperoxy-esters isolated from a severely diseased 
aorta. The reduction of the hydroperoxides to the 
hydroxy-esters with sodium borohydride is also illustrated. 
Mobile phase: benzene:ethyl acetate (20:1 v/v).
o \1 S B-30 
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FIG, 23c Gas-liquid chromatogram of h y d ro x y  acid methyl esters
derived from aortal hydroperoxides* Peak 1 corresponds 
to a mixture of the 9-hydroxy-10-trans,12-cis- and 
13“hydrox3r»9“'CiSj 11 -trans-ockadecadienoic acid derivatives. 
Peaks 2 and 3~Tvery slightly resolved) are the all-trans
9- and 13-hydroxy-acid derivatives respectively.
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3.2. THE OCCURRENCE OF HYDROPEROXY-- AND KETO-ESTERS
IN ADVANCED AORTAL LESIONS
3.2*1# Identification of Aortal Hydroperoxy-esters.
During our work on the characterisation of hydroxy sterol
esters isolated from aortal lesions we have frequently observed
material with a mobility on TLC intermediate between hydroxy-
esters and triglycerides. Preparative TLC (mobile phase:
benzene: ethyl acetate, 20:1 v/v) of column eluates containing
this material, allowed the separation of three bonds at R^s =
0.67, 0.61-0.50, and 0.43-0.33, corresponding respectively to
triglycerides, a group of previously unidentified compounds, and
hydroxy-esters (Pig. 20). The central band was further purified
by preparative TLC, and thus rendered free from hydroxy-esters
and triglycerides. Examination by ultraviolet spectrometry
(Pig. 21) disclosed an absorption at A mQX = 233 nm ( 6 , ^  ££.
20,000) characteristic of a conjugated diene. Weak absorption
of. 1 — 272 nm was ascribed to small quantities of a conjugated
max
dienone. Thin layer chromatography of the isolated material 
showed it to be identical to hydroperoxides of cholesteryl linoleate 
prepared ly autoxidation, both in R* value, and in its reaction 
with eerie sulphate and potassium iodide spray reagents (Table 5).
Reduction of the isolated material with sodium borohydride 
produced a group of compounds identical in TLC properties to 
hydroxy-esters (Pig. 22, Table 5). Alkaline hydrolysis of the 
reduced material yielded an acidic fraction which was methylated, 
trimethylsilylated and examined by GLC. Three peaks corresponding 
to methyl trimethylsilyloxy-octadecadienoates were observed (Pig. 
23). The retention data of the isolated derivatives were 
compared with those of available reference compounds. The results;
9-OTMS 1 0 - trans 12—cis
13-OTM5 9 -c is  11~trans
382
130
225
335 339
143 '239 253 272 292155 351 367325
111 UJ.L 111 iiiit»lu. l : 
PEAK 2 ■>  X 51=2360
9-OTMS 10-trans  12 -trans
13—OTMS 9 - trans 11 — trans 382
130
225
335 339 
375! Jyt2 3 P  253 272 2?2
PIG* 2if. Mass spectra of the hydroxy-acid methyl ester TMS ethers 
derived from aortal hydroperoxides. Ions of n/e greater
than 2"50 are represented at 5 X their true relative intensit}7
312 0
3230
m inutes.
FIG. 25, Gas-liquid chromatogram of the bis TMS ethers of 7*-* 
hydroxycholesterol (Peak a )  and ")/i•bydrcsycholesterol
(Peak B) derived from aortal hvdropero>y*»esters8 1fo
JSE-30, 21.0°G.
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are summarised in Table 7* Mass spectra recorded during GLC of 
the isolated derivatives are shown in Pig. 24. Peaks 2 and 3 
were not resolved under the conditions used. The two mass spectra 
recorded are consistent with those of 9*" and 13“* trimethylsilyloxy— 
octadecadienoates.
Reductive cleavage of the isolated hydroperoxy-esters gave a 
mixture of sterols and octadecadienediols. Preparative TLO on 
silica gel (mobile phases chloroforms ethyl acetate, 3s 1 v/v) 
revealed four bands at Rf = 0.70, 0.5k, 0.47 and 0.27. Material 
in the most mobile band was identified as cholesterol by TLC and 
GLC. Triraetbylsilylation of the least mobile band, and subsequent 
analysis by TLC and GLC (Pig. 25) indicated the presence of two 
sterols whose chromatographic behaviour was consistent with the 
epimeric 7-hydroxycholesterols (Table 6).
Fractions 1 (R^ a 0.54) and 2 (R^ = 0.47), containing octa­
decadienediols were trimethylsilylated and examined by GLC. 
Chromatograms of the TMS ethers of the diols, before and after 
separation by TI£ are shown in Pig. 26.
Fraction 2 contained two principal components with retention 
indices of 2350 and 2400, corresponding respectively (Table 9) to
10-trans. 12-cis- and 10-trans. 12-trans-octadeoadiene-l. 9 diol bis- 
TMS ethers* The derivatives from Fraction 1 also contain two 
major components with retention indices of 2350 ani 2415. The 
former value corresponded to that of standard 9-cis. 11—trans— 
octadecadiene-1,13 diol bis-trimethylsilyl ether, and the latter 
is most likely the corresponding trans. trans derivative. The 
mass spectra and significant fragmentations of the components of 
Fractions 1 and 2 are shown in Fig. 27. The mass spectra of both 
peaks in Fraction 1 are identical, and correspond to the cis, trans— 
and tr^ns. tr*»ns— octadecadiene-1,13 diol bis TMS ethers (cf. Fig. 7).
)L JXR
180° C
JXR
180 C
1,9—  DI—  O T M S —  
-OCTADECANE
1,13-DI-OTMS-
—  O C T A D E C A N E
2365
2375
0 6A2 26 0
minutes minutes
FIG-, 28* G-as-liquid ehromatogi'ams of octadecanediol-bls TMS 
ethers prepared by hydrogenation of the dienes from 
fractions 1 and 2.
FR ’2 ( t  = 2365)
iOTMS
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OCTADECANEDIOL BIS TMS ETHERS FROM AORTAL HYDROPEROXIDES
FIG-. 29« Maas spectra of octadecanediol-lbis TMS ethers prepared by 
hydrogenation of the dienes from fractions 1 and 2.
20
A REFERENCE MIXTURE 
OF HYDROPEROXY AND 
KETO ESTERS.A max= 26 81-6-
CORRESPONDING MATERIAL 
FROM DISEASED AORTA
IN­
SOLVENT^ HEXANE
A  max=267
00
450200 225 400250
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350325300275
i
FIG-. 30. Ultraviolet spectra, of reference and arterial mixtures of ,hydropero:<y* 
and keto-esters of cholesterol,. The spectrum of the isolated sample 
indicates an excess of keto-esters,,
80
Similarly the TMS ethers of material from Fraction 2 have mass, 
spectra characteristic of the isomeric 10,12—octadecadiene—1,9 “ 
aiol bis-TMS ethers (cf. Fig. 10). Hydrogenation of Fractions 
1 and 2 each resulted in one major peak on GLC of the TMS 
derivatives (Fig. 28). The mass spectra of the tetrahydro TMS 
ethers con film the presence of octadecane—1,9'" diol and octadecane- 
1,13-diol as the major products of hydrogenation (Fig. 29).
The quantities of cholesteryl linoleate hydroperoxides present 
in the extracts were determined by GLC of the derived hydroxy-acid 
methyl ester TMS ethers, as described on Page 52. In two 
separate cases the quantities of hydroperoxides were determined 
to be 55 yttg. and 178 jig* per g. of total lipid. The quantities 
of hydroxy-esters in advanced lesions are between 5 and 10 times 
greater than the quantities of the corresponding hydroperoxides.
3# 2.2* Identification of Aortal keto-esters.
During examination of plaque hydroperoxy-esters, ultraviolet 
spectra were obtained of purified material from several different 
aortal extracts. It was observed that quantities of ketonic 
material with an absorption at A = 272 nm (268 nm in hexane) 
varied considerably from one extract to another. In most cases 
there was a large excess of hydroperoxy-esters (Fig. 21), however 
occasionally the quantities of keto- and hydroperoxy-esters were 
similar, and in the instance of one extract described below there 
was a large excess of keto-esters.
After isolation of the appropriate material corresponding by 
column and thin-layer chromatography to hydroperoxy- oxid/ or keto- 
esters, a sample was examined by ultraviolet spectroscopy. The 
solvent used was hexane, since it had been found that small 
quantities of lipid were more easily recovered from this solvent
O C T A D E C A D I E N E D I O L  BIS TM S
ET H E R S  D E R IV E D  F R O M  A O R T A L  
K E T O  E S T E R S .
9', 1°/o SE—3 0 ,  2 2 0 ° C .
2 3 8 0
2 3 4 0 1
minutes
FIG* 31, Gac-liquid chromatogram of octadecadienediol-bls TMS ethers 
derived from aortal keto-esters b;y treatment with LiAlD^e 
The peak with I - 2340 is a mixture of 10-trans,12-ois- 
octadecadiene-1 , 9“ and 9“£is$ 11 -trans-octadecadiene-1 , 13 
diol-bis TMS ethers* The peaks with I 2380 and 2400 are 
the trans*trans isomers of the respective 1,9“ and 1,13“ 
diol derivatives.
jOTMS
CH3(cH2) - : iD  - C H = C H - C H = C H  
<_ 3^58
CD-OTMS
130
131 358
429
339
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OTMS2360
CH CH ICH— C H -  C H = C H — CDt  ( CH -CD-OTMS
226<-
73
130 ,429
OTMS t t , v .
CH„(CH tC D -C H -C H - CH~CH-(CH^ ]CQ,-OTMS 
3V 2/ l--------358
358
226I -  2400
130
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429
FIG-. 32„ Mass spectra of the oetadgcadienQdiol~bis TMS ethers derived from 
aortal keto-esters by LiAlDi reduction. The mass spectra were 
scanned at the retention indices indicated (c,f. Fig. 31).
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than from ethanol. The resultant spectrum is shown in Pig, 30 
and implies a large excess of keto— over hydroperoxy-esters in 
the sample. Re-examination of the material by analytical TLC 
showed that it gave only a very slight reaction when sprayed with 
potassium iodide solution, but reacted strongly when sprayed with 
2,i^-dinitrophenylhydrazine reagent. It appeared, therefore, that
the bulk of this sample consisted of keto-esters. Since the 
sample was so small (approx, 80jug, as determined by U.V, spectro­
scopy), the selective reduction of the bydroperoxy-esters 
described on page 76 was not attempted* The material was reduced 
with lithium aluminium deuteride as described for keto-esters 
(page 55 ) and the octadecadienediols and sterols thus produced 
were separated by preparative TLC (mobile phase: chlorofom:etiyl
acetate, 3s 1 Vv) on a micro plate* After separation from 
cholesterol (R^ = 0,68) and the 7-hydroxycholesterols (R^ = 0,25), 
the band at R^ > = 0,48 corresponding to octadecadienediols, was 
trimethylsilylated and examined by G-LC. The chromatogram is 
reproduced in Pig, 3^  and shows the familiar pattern of peaks 
corresponding to a mixture of octadecadienediol bis-TMS ethers*
Mass spectra of the three major peaks were obtained and line diagrams 
are shown in Pig, 32, As previously mentioned, formation of the 
deuterium labelled octadecadienediols can permit differentiation 
of keto- and hydroperoxy-esters* The mass spectra reveal deuterium 
labelling at the carbon atom attached to the secondary trimethyl- 
silyloxy function, indicated by the ions at values a 226, 358, 429 
(M+*), and the doublet at = ^30 ®nd 13*f (®£* Fig* 18), Since 
the 1,9- and 1,13-octadecadienediols were not in this instance 
separated by preparative TLC, that peak with retention index I a 234-0 
is a mixture of the 10-trans. 12-cis-octadecadiene-1,9-diol and the 
9 cis, 11-trans-octadecadiene-1,13-diol bis-TMS ethers* The all—
82
trans isomers are however, resolved, mass spectra being scanned 
at I = 2380 (l,9-diol-bis TMS) and I a 21+00 (1,13-diol-bis TMS).
The mass spectra substantiate the ultraviolet spectral evidence 
that the original keto-esters were almost completely free of 
hydroperoxy-esters. Had significant quantities of the latter 
been present, the ratio of the ions a 130:1^6 a i 31 would have 
been expected to be much greater, since n/<e a 131 is characteristic 
only of such derivatives from keto-esters.
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3.3* THE OCCURRENCE OF HYDROXY STEROL ESTERS IN VAKIOUS
STAGES OF HOMAN ATHEROSCLEROSIS
The presence, in severe atheroma, of a group of hydroxy
1 ?5 127
sterol esters has been recently described.- 9 Certain of these 
esters have been shown to consist of mono-esters of hydroxy- 
sterols , viz., 7*-hydroxycholesterol, 7^-hydroxycholesterol, 
2^-hydroxycholesterol and 26-hydroxycholesterol. A second class 
of hydroxy sterol esters, which comprises the larger part of the 
group, is composed of cholesterol esterified with hydroxy—acids. 
Three of these acids have been identified , via., 9~hydroxy-10- 
trans. 12-cis-octadecadienoic acid, 9-hvdroxy-10-trans, 12-trans-
octadecadienoic acid, and 15-hvdroxv-9-cis« 11-trans-octadecadienoic
125 127
acid. Previous work # was concerned with the isolation and 
identification of these acids from severely diseased arteries.
The present study compares the quantities of the various hydroxy— 
octadecadienoio acids derived from hydroxy-esters isolated at 
various stages of the disease.
Human aortas were collected within 2k hours of death. The 
age, sex and principal cause of death of each subject are given 
in Table 11. The degree of arterial disease was graded, I, II 
or i n  according to the classification described on Page 17. 
Plaques were disected, and those of similar grade were collectively 
extracted as previously described, page k5. Fractions containing 
hydroxy-esters were obtained by silicic acid column chromatography, 
and the esters were purified by preparative TLC (Fig. 20). The 
weights of total lipid, and the percentage of sterols and sterol 
esters isolated by column chromatography are given in Table 12.
The mean weight ratios of free sterol to sterol ester were 0.52 
in Stage I, 0.W in Stage II, and 1.06 in Stage III. Hydrolysis 
of the tydroxy sterol ester fractions from both Stage II and Stage 
III yielded a mixture of sterols (mainly cholesterol, together
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with hydroxycholesterols), and fatty acids. The hydroxy-acids 
were methylated, trimethylsilylated and examined by GLC. Three 
hydroxy-acids were identified, viz., Acid 1 (13-hydroxy-9-cis,
11-trans-octadecadienoic acid), Acid 2 (9-hydroxy-10-trans, 12- 
cis-octadecadienoic acid), and Acid 3 (9-hydroxy-10-trans.12- 
trans-octadeoadienoic acid). The identities of these acids have 
been rigorously determined during previous work.^^’ hydrolysis 
of fractions from Stage I cases, corresponding in chromatographic 
behaviour to hydroxy sterol esters, yielded neither sterols nor 
hydroxy-acids in detectable amounts. The minute amounts of 
saturated and unsaturated fatty acids found in such fractions were 
probably present in the tissue as free fatty acids. The quantities
of hydroxy-acids isolated from Stage II and Stage III type tissue
were determined as their methyl ester trimethylsilyl ethers as 
described on page 52, Table 12 shows the amounts of hydroxy-acids 
determined per g of total lipid in each case. The quantities of 
cholesteiyl hydroxyoctadecadienoates, expressed as a proportion of 
the total sterol esters,are indicated in the final column of Table
12, Individual quantities of Acids 1 and 2 were not determined,
because their derivatives were not effectively separated by GLC,
The results indicate a statistically significant rise from 
89*50 g/g (hydroxy-acids/total lipid; mean * standard deviation) 
in extracts representing Stage II of atheroma, to 335-150 g/g in 
the Stage III extracts (t = 3.47, P = 0.004). The concentration 
of the cholesteryl octadecadienoates rose from 420*210 g/g 
(hydroxy-ester^/total sterol esters) in Stage II to 1950-900 g/g 
in Stage III (t = 3.58, p = 0.004). There is virtually no overlap 
in the ranges of individual results for the three classes of lesion.
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3.4. THE ISOLATION AND IDENTIFICATION OF 5«-CHOLESTAN-51-OL
FROM THE HUMAN ATHERCMATOUS AORTA
116
A preliminary study of the companion sterols of cholesterol 
occurring in advanced atheroma has demonstrated the presence of 
small quantities of cholesta-5,24-dien-3^ -ol (desmosterol) and 
cholesta-3,5-dien- 7-one. The purpose of the present work was
to determine the nature and quantities of saturated close relations 
of cholesterol reported fry several workers to be present in extracts 
from human atheroma,
5*-Cholestan-3/f‘,*ol (cholestanol) has been identified as a
109,110,267
companion sterol of cholesterol in several human tissues
111.268
including arteries. There is, however, considerable doubt
as to the quantities of this sterol present in the total sterol 
fractions. The older literature on atheroma1 °^’1^  contains 
reports of proportions of cholestanol as high as 13$ of the total 
sterols. Recent reports1 ^ ,111however, based on improved 
analytical methods, suggest that it amounts only to about 0.5 - 
1$ of the total sterol in tissue, Cholestanol and cholesterol 
are very difficult to separate by conventional column or thin-
269
layer chromatography. While they may be separated by GLC
the fact that cholestanol is often present in quantities of around
0.1$ of the sterol mixture renders the analysis difficult. One
270
method of circumventing this difficulty involves oxidation of
cholesterol to cholestane-3y?, 5*6^triol which is readily separated
271-273
from unoxidised cholestanol fry solvent extraction or silicic
109acid chromatography. Saturated sterols may then be analysed by
GLC, ^ 1or ty precipitation with digitonin and the quantities
109
determined either gravi metrically or via the anthrone method.
The outstanding disadvantage of this method is that minor quantities 
of olefinic sterols which may also be present in the sample would
86
also be irreversibly altered. An alternative to oxidation is 
removal of cholesterol by chromatographic methods prior to 
analysis by GLC. Thin-layer chromatography over silica gel
1/1 97J
impregnated with silver nitrate ' offers this alternative.
In this method sterols are differentiated according to the number 
and position of the olefinic bonds in the molecule, and thus 
chromatographic separations can be effected. Separations can
p"7C 0~lf>
be enhanced by the preparation of derivatives such as acetates *
2h3and propionates, but in this study it was desirable that such 
derivatives should also have informative gas chromatographic and 
mass spectral properties*
Preliminary investigations showed that although acetates 
and propionates were satisfactory derivatives for thin-layer 
chromatographic separation of cholesterol and cholestanol, the 
mass spectra of such compounds did not normally show molecular 
ions. Conversely use of trimethylsilyl ethers (which have 
excellent GLC and mass spectral properties ) demonstrated their 
unsuitability as derivatives for effecting separation of cholestanol 
and cholesterol on silver nitrate impregnated layers, poor 
separations and considerable decomposition being shown to occur.
The use of trifluoroacetylation afforded derivatives which
yielded clean separations on TLC, convenient retention times on
27B
GLC and good mass spectral properties. Accordingly, this study
of the companion sterols of cholesterol was initiated using tri— 
fluoroacetates.
Plaques from grossly diseased aortas were processed and 
sterol and sterol ester fractions were isolated as described on 
page . Polar sterols were removed from the total sterol 
fraction by repeated crystallisation from methanol. Sterol esters 
were subjected to alkaline hydrolysis in methanolic KOH for 15 hours.
1 1 3  4 -  S '  6
FICr, 33* Thin-layer chromatogram of reference cholesteryl and 
cholestanyl trifluoroacetates, and the corresponding 
derivatives of sterols isolated from arterial lesions. 
Lane 1: cholesteryl TFA; Lane 2: cholestanyl TFA;
Lane 3i mixture of cholesteryl and cholestanyl TFAs;
Lane l^ s TFAs of a mixture of sterols isolated from
arterial lesions; Lanes 5 and 6 respectively show
cholestanyl and cholesteryl TFAs after separation of the 
mixture shown in Lane 4*
Silica gel (Adsorbosil l) impregnated with 26% (w/w) 
AgNOjj, Mobile phase: hexane:benzene (97s3 V v)c
3375
minutes
PIG-, 3k. Gas-liquid chromatogram of a fraction (c»f, Pig, 33* Lane ,5) 
largely comprising the trifluoroacetates of cholesterol (a) 
and cholestanol (B), isolated by TLC from an extract of the 
saponified sterol esters of human atheromatous plaoues, 1 fo 
QP-1, 200°C,
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Sterol trifluoroacetates (prepared as described on page 57 ) 
were subjected to preparative TLC on silver nitrate impregnated 
layers using a mobile phase of hexane: benzene (97:3 Vv). In 
a typical example the cholesteryl trifluoroacetate band (Rf = 0.45) 
was located with iodine vapour, and the area immediately above 
was removed from the plate and extracted with hexane. After 
concentration the eluted material was examined by analytical TLC 
(Fig, 33)• Two spots were obtained which were found to corres­
pond to cholesteryl and cholestanyl trifluoroacetates in both 
Hf values and in colour reaction. Examination by GLC demonstrated 
that approximately 90/o of the sample was cholesteryl trifluoro­
acetate, A second thin-layer chromatographic separation reduced 
the proportion of cholesteryl trifluoroacetate to about 35$ as 
indicated by the gas-liquid chromatogram (Fig, 34) • Peak B 
corresponded in retention time to cholestanyl trifluoroacetate.
In one instance the bulk of the fraction containing purified 
cholestanyl trifluoroacetate was subjected to alkaline hydrolysis 
and the free stanol and its trimetbylsilyl ether were examined by 
GLC. Comparison of retention times with those of reference 
compounds gave satisfactory correlations (Table 13)* The identific­
ation was confirmed by GC-MS of the trifluoroacetates and tri­
ms thy Is ilyl ethers of the isolated material. The mass spectra 
were found to be identical to those of the corresponding derivative 
of cholestanol (Fig, 35), The stereoisomers 5eC-cholestan-3*-ol, 
5y*-cholestan-3/?-ol and 5^-cholestan-3*-ol all gave very similar 
mass spectra as their trifluoroacetate, but are clearly distinguished 
by their retention characteristics on GLC (Table 13), 
5*-cholestan-3^-ol is the only isomer for which the derivatives 
have longer retention times than those of cholesterol.
There was no evidence for the presence of other stanols
17- 9 2 0  2 1 2?
&
■
%
tVNwjV*' :
Rf 0-60
0-40
!j\ 0-20
ORIGIN
FIG. 36. Thin-layer chromatogram of fractions (numbered 17-22) eluted 
in 15-20^ chloroform in hexane during silicic acid column 
chromatography of an extract from advanced aortal lesions. 
Mobile phase; hexane:benzene (2:1 v/v), Region at R^ 0.39-0.58 
contains cholesterol esters. Region at Rf 0.1-0.2k- contains 
sterol diesters.
88
either in the free or esterified sterol fractions from the 
extracts which were studied. The amounts of cholesterol 
isolated were estimated by gas-liquid chromatography to represent 
between 0,3 0*5$ of the total in both free and esterified
sterols isolated from plaques.
3*5. THE ISOLATION AND IDENTIFICATION OF PI-ESTERS OF
26-Hn)R0Xr0H0LESTER0L FRCM HUMAN AORTAL LESIONS.
The sterol ester composition of human arterial lesions has
been extensively investigated; see reviews by Bottcher and
89 279
Woodford, and Swell and Treadwell, The advent of gas chromato­
graphy has enabled rapid and accurate identification of the 
individual components in mixtures of fatty acids, and much 
attention has been devoted to comparative studies of the nature
and quantities of fatty acids present as cholesterol esters in
88,100-103
varying types of lesions. More recently it has been shown
that small quantities of esters of sterols other than cholesterol
125)-127
also occur in diseased aortal tissue. Besides esters of
cholestanol (a very frequent companion of cholesterol in many tissue
125-127
extracts) , other esters have been found and shown to
consist of mono-esterified hydroxy sterols, namely, 7^-hydroxy- 
cholesterol, 7^-bydroxycholesterol, 2^-hydroxycholesterol and 26- 
hydroxycholesterol. The present work demonstrates the occurrence 
and describes the identification of a hitherto unknown type of 
sterol ester. Examination by TLC of the later of the column 
fractions containing cholesterol esters, using a mobile phase of 
hexane: benzene ( 2i 1 "v/v) revealed material of slightly greater 
polarity than the cholesterol esters (Fig. 36). The material of 
Rf range 0.08 to 0.21 was partially freed from cholesterol esters 
(Rf 0.35-0.55) by preparative TLC, and hydrolysed to yield acid
iG, 37® G-as-liquid chromatogram of TMS ether of oholest-5~ene~3 , 
26-diol obtained from aortal diesters. Peak 1, cholest- 
5-ene-3 ' "0- TMS ether? Peak 2, cholest-5~ene-3 #26 diol 
bis-TMS other. 1$ SB-30, 240°C.
of Free 
Sterol 
(CHCEL^ EtQ/ie
3:1 v /v )
Hf of 'MS Ether
( Hexane:Bensone 
2s 1 v /y )
T 2kO°G 
1jS SB-30
26-fcydroxy- 
cholesterol 0.37 0.31 3M-5
Sterol isolated 
from di esters 0.37 0«J3 3U-5
TABLE 14, Comparison of chromato^ rcaphic data of the sterol
isolated from diostors watli those of authentic 26- 
hy dxoxy ehc-lestorol. Geo chroma tographie data refer
to the sterol big,-IMS ethers.
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FIG* 39, Comparison of gas chromatograms of the fatty acid methyl esters 
derived .from cholesterol ester and diesher fractions from the 
same severely diseased aorta,
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and neutral fractions. Examination of the latter on TLC both 
as the free sterols and as the trimethylsilyl ethers showed the 
major component to be indistinguishable from 26—hydroxycholesterol 
(Table 12*.), The trimethylsilyl ether of the hydroxy sterol was 
examined by GLC and mass spectrometry and thus positively 
identified as 26-hydroxycholesterol (Figs, 37 and 38),
For a study of the acids esterified with 26-hydroxycholesterol 
the di-ester fraction was purified twice by TLC, thus reducing 
the quantity of cholesterol ester present to less than 5$ (as 
judged by GLC of the sterols liberated on hydrolysis), The acid 
fraction from hydrolysis was methylated with diazomethane and 
examined by GLC on several different stationary phases. The 
fatty acids characterised and their relative proportions (means 
of five determinations) are given in Table 15. The major acids 
(palmitic and oleic) account for approximately 57$ of the total. 
Comparative data are included for the fatty acids isolated from 
the cholesterol esters of 3 of the lipid extracts studied.
Figure 39 compares the fatty acids esterified with 26-hydroxy­
cholesterol with those of cholesterol in the same extract of a 
badly diseased aorta. The virtual absence of linoleate and the large 
quantities of palmitate, stearate and oleate in the former are 
contrasted with the expectedly htigh linoleate concentration in 
the chiolesteiyl esters.
In order to identity further the diesterified 26-hydroxy­
cholesterol present in aortal extracts, the synthesis of a model 
compound was undertaken.
Preparation of 26—hvdroxycholesterol dipalmitates
26-lydroxycholesterol was prepared by the method of Scheer 
et al.28l the corresponding diacetate, reoiystallised from ethyl
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acetate, had m.p. 127~128°. The dipalmitate was prepared using
?8o
the method of Mahadevan and Lundberg “ for preparation of 
cholesterol esters, A mixture of 26-}ydroxycholesterol diacetate 
(100 mg), methyl palmitate (135 mg), and sodium ethoxide (5 mg; 
prepared in situ from clean sodium and freshly dried ethanol) was 
heated at 90°C under vacuum (20 mm Hg) for 1 hour. The residue 
was extracted 3 times with 10 ml portions of benzene, and the 
filtered extract was concentrated to small volume. The product 
was purified by preparative TLC using benzene; ethyl acetate (20:1 
v/v) as mobile phase. The Rf of the dipalmitate was 0.73. 
Recrystallised from ethyl acetate, it had m.p. 56-57°0 (Found: 
0,80.57; H,12.10. 059% ) ^  requires 0,80.57; H,12.15). The
infrared spectrum showed ^ Cs0174-0 cm~^, £ maX 970 (cf. cholesteryl 
palmitate ^ Css0 1740 cm~^>£max 520), and no hydroxyl absorption.
The yield was 28 mg (17$).
The constitution of the dipalmitate was confirmed by reductive 
cleavage, followed by estimation of the products by gas chromato­
graphy as follows: a weighed sample (2-6 mg) of the ester was
reduced with lithium aluminium hydride. The products were 
extracted with 5 x 10 ml portions of ethyl acetate, trimethyl- 
silylated and examined by GDC. The retention indices of the 
derivatives of the reduction products were compared with those of 
standards and the quantity of each component was determined. The 
results are given in Table 16.
The chromatographic behaviour of the isolated and synthetic 
esters was compared* The right-hand side of Fig, i#0 shows the 
edge of a preparative thin-layer chromatogram which has been 
destructively sprayed and charred. The isolated di—esters were 
well separated from cholesterol esters (Rjp 0.89-pOo95) &nd tri­
glycerides (Rf 0.27). The left-hand side of Fig. hD demonstrates
SOLVENT FRONT
(CHOLESTEROL
ESTERS)
Rf 0-54 
(DIESTERS)
i
Rf 0-27
(TRIGLYCERIDES)
ORIGIN
PIG. 40. Thin-layer chromatograms comparing synthetic and extracted 
diesters of 26-hydroxycholesterol.
R.H.S.: Edge of preparative plate which has been destructively
sprayed and charred after removal of the bulk of the diesters 
isolated from an aortal extract. Rf cholesterol esters 0,93* 
diesters 0,54* Rf triglycerides 0.27, Mobile phase: benzene:
hexane (2:1 v/v).
L.H.S,: Analytical chromatogram comparing purified material from
extract with authentic 26-hydroxycholesterol dipalmitate.
Lane A, authentic cholest-5-ene-3^,26 diol dipalmitate (Rf 0,56); 
Lane B, purified diesters from aortal extract (Rf 0.54);
Lane C, standard cholesterol (Rf 0,03) and triolein (Rf 0.27). 
Mobile phase: benzene:hexane (2:1 v/v).
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the identical chromatographic behaviour of isolated and synthetic 
di-esters of 26-hydroayc hole sterol. Quantitative analysis of
the lipid extract derived from plaques from a severely diseased 
aorta, using the method described on page 53, demonstrated the 
presence of 120 £ 6yUg of 26-hydroxycholesterol di-esters per g 
of total lipid. A similar extract from an aorta affected only 
by "fatty streaks" yielded 63 ± 3y^g of di-ester per g. of total 
lipid.
i-
92
3.6# ANALYSIS OF INTACT CHOLESTEROL ESTERS BY COIvIHjE]\1ENrAHT
USE OF TLC .AND HIGH TMPSRATUHE GLC.
Detailed studies of cholesterol esters and triglycerides 
occurring in aortal tissue have hitherto involved hydrolysis of 
the esters and separate characterisation of the products. The 
principal advantage of this approach is the ease with which fatty 
acid esters may be separated and identified by GLC, However, for 
very small quantities of lipid, such as are obtained from cerebral 
and coronary arteries, such a procedure may result in contamination 
of the hydrolysis products with organic impurities such as 
plasticisers,233~237
The occurrence throughout the spectrum of arterial disease,
of varying quantities of cholesterol esterified with polyunsaturated
CgQ fatty acids may be of importance as a reflection of the changes
101
in mural metabolism as atherosclerosis advances. We have
experienced some difficulty in identifying such esters because of
their rather small abundance in the total cholesterol ester fraction,
and have noted that use of the polyester phase EEG-A, does not
achieve gas chromatographic separation of methyl 8,11, 1Jj.-eicosatrienoate
237from the ubiquitous plasticiser di-n-butyl phthalate.
A convenient alternative to the hydrolysis procedure is direct
examination of the cholesterol esters by purely chromatographic
methods. The use of GLC at high temperature can effect separation
of cholesterol esters and glycerides containing different numbers
of carbon atoms,1 88~1 ^  TLC on layers impregnated with silver ion
permits separation of lipids according to the number, position and
141
configuration of their olefinic bonds. It seemed likely that
a combination of these techniques might be advantageous for 
characterisation of arterial cholesterol esters.
The major disadvantage in the use of G-LC at temperatures in
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excess of 250°G is the limited number of thermally stable liquid
stationary phases, and most work of this type has utilised the
188-190 . 191
siloxane or poly—carborane siloxane type polymers*
In the present work the thermal stability of the methyl siloxane 
polymer SE-30 was investigated*
Column packings of 1^ SE-30 on Gas Chrom Q were purchased from 
Applied Science Laboratories, The packed columns were conditioned 
by gradual increase in temperature from 100° to 360°C over a period 
of 5 days* The thermally Mstripped” SE-30 was tested by analysis 
of a series of saturated cholesterol esters with acid chain lengths 
ranging from 11 to 24 carbon atoms* A typical chromatogram 
obtained by isothermal analysis at 320°C is reproduced in Pig. A1. 
Analysis of a limited number of triglycerides at 350°C demonstrated 
equally satisfactory results (Fig, 42),
There is a limited availability of suitable reference hydro­
carbons for retention data standardisation of cholesterol esters.
The esters may be assigned relative retention times with respect 
to an arbitrary standard, but inaccuracies in such a system 
frequently occur when standard and sample have considerably different 
retention times. However, a plot of Log retention time against 
the number of carbon atoms in the acid moieties of a series of 
saturated esters was found to be satisfactorily linear. On this 
basis retention data for other cholesterol esters may be standardised 
relative to the series of saturated esters, the samples being given 
index values analogous to the ,Tequivalent chain length” values so 
widely used in GLC of fatty acid methyl esters. Retention data 
for available unsaturated cholesterol esters are given in Appendix I, 
and indicate that esters differing only by their degree of unsaturation 
may not be separated on this stationary phase* The usefulness of 
such a gas chromatographic system was demonstrated by its application 
to the analysis of aortal cholesterol esters.
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PIG-, A3. Thin-layer chromatogram illustrating separation of arterial 
cholesterol esters on silver nitrate impregnated layers.
Lane 1, cholesterol esters of saturated fatty acids;
Lane 2, esters of monoenoic acids; Lane 3, esters of 
dienoic acids; Lane A, esters of trienoic acids; Lane 5* 
esters of tetraenoic acids; Lane 6, total mixtures of esters, 
Kieselgel G-HR impregnated with 12^ (w/w) AgNO^, Mobile phase; 
benzene:hexane (2;1 v/v),
[DIENEl[MONOENEi
16:1
18:0
minutes
2 0 :3FR -4 
(TRIENE) [TETRAENE]
2 0 :4
18:2
FIG-c 44* G-as-liguid chromatograms of aortal cholesterol esters 
after fractionation by preparative TLC on silver 
nitrate impregnated layers* The figures above each 
peak designate the number of carbon atoms and the 
degree of unsaturation of the fatty acids with which 
cholesterol is esterified. 1$ SE-30, 320°C,
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Cholesterol esters were isolated from the total lipid extract 
of a severely diseased aorta, as described in Section 2.4. The 
esters were fractionated according to their degree of unsaturation 
by TIC on silica layers impregnated with silver nitrate (Section 2,5)* 
Two mobile phases were employed for TLC. The first, benzene:hexane 
(2:1 v/v) affords separation of unsaturated, mono- and di-unsaturated
esters (Fig, 43)* Polyenoic esters were separated using a mobile 
phase of benzene:ethyl acetate (20:1 v/v).
Five fractions corresponding respectively to saturated esters, 
monoenes, dienes, trienes, and tetraenes were obtained. Each fraction 
was examined by GLC, and the chromatograms are presented in Fig. 44*
The identity of the esters isolated in the triene and tetraene 
fractions were established by alkaline hydrolysis and examination of 
the acid methyl esters by GIC and GC-MS. Two peaks were observed 
in the chromatogram of methyl esters derived from the triene fraction. 
The smaller peak with corresponded to methyl linoleate
both by retention index and mass spectral correlations. The major 
peak 2805 had a molecular weight of 520 indicative of a tri­
unsaturated C20 ester. The retention index of this compound did not
coincide with that of reference methyl 11,14,1'7-eicosatrienoate, and
103is most probably the 8,11,14 isomer,  ^ The single peak in the
methyl ester fraction derived from tetraenoic cholesterol esters was
identical both in retention index (l^cvf**~ 284°) and molecular
200 0
weight (M** » 318) to methyl arachidonate. Cholesterol esters of 
arachidonic and eicosatrienoic acids have been identified by several 
investigations,101*10  ^ While we cannot claim that the chromatographic 
methods described above afford ary considerable advantages over
conventional analysis of mixtures of cholesterol esters, they may 
find application in studies of esters consisting of more than one 
sterol type. Further applications of sterol ester gas chromatography
are being investigated.
Section 4. DISCUSSION
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FIG. 4-5• Formation of linoleate hydroperoxides via autoxidation.
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Formation of linoleate hydroperoxides by the concerted 1,4 
addition of singlet oxygen.
THE OXIDATION OF CHOLESTEROL LINOLEATE 
Although studies of the oxidation of linoleic acid and metiyl 
linoleate have been extensive, little work has been done on the
pop
oxidation of the cholesterol ester, Kauftnann and co-workers 
prepared cholesterol esters of hydroxy- and keto-acids by autoxidation 
of cholesteryl linoleate in the presence of haemoglobin, and noted 
that in the production of these compounds, hydroperoxides exhibiting 
diene conjugation were produced. The products of oxidation were 
not fully characterised. Although the present reason for the 
preparation of oxygenated derivatives of cholesteryl linoleate was 
to obtain reference compounds with which we could compare material 
isolated from tissue extracts, a brief discussion of the mechanisms 
whereby the identified products are formed is relevant.
The products of cholesteryl linoleate autoxidation and photo­
oxidation are dissimilar, but their formation may be rationalised
on the basis of the mechanisms proposed for related oxidations of
283linoleic acid, Autoxidation of linoleate proceeds via a free 
radical mechanism as shown in Fig, 45. Following radical formation 
by hydrogen abstraction, double bond migration occurs to give a 
conjugated diene system. Subsequent attack by molecular oxygen 
produces a peroxy radical, and abstraction of hydrogen from another 
molecule results in hydroperoxide formation at either or
of the fatty acid chain. Hydroperoxides of linoleate produced by 
autoxidation all contain a conjugated diene system. In contrast, 
the hydroperoxides arising by photosensitised oxidation have been 
shown to arise in a completely different way. This reaction 
involves a concerted 1,4 addition of singlet oxygen ( Og) to the 
olefin (Fig, 45), Singlet oxygen may be produced by the action 
of a sensitiser (methylene blue in the present work) on ground state 
triplet oxygen. Since there are four olefinic carbon atoms in the 
acid, four positional isomers may occur. The concerted "ene"
97
mechanism has been questioned in favour of a two step perepoxide
. .  2 8 k , 2 8 5  ^  ^ 286
reaction but more recent work substantiates the former:
the products expected from linoleate photo-oxygenation would be
the same in both cases, As illustrated in Fig, k6, the migrating
double bond may or may not give rise to a conjugated system, and
a mixture of conjugated and non-conjugated hydroperoxides will be
produced,
The structures predicted by the above mechanisms agree very 
well with those assigned in Section 3,1, The trans,trans isomers 
of the 9- and 13-hydroperoxy-esters, although not predictable by 
mechanistic considerations are to be expected by analogy with 
previous work on linoleic acid, in which appreciable quantities of 
these isomers result from prolonged autoxidation at room temperature.
It is known that conjugated acids stereomutate more readily than 
the non-conjugated compounds. The former react readily with iodine 
in the presence of light at room temperature, whereas in the case of 
the latter stereorautation generally requires heating with selenium 
(^200^0) or with a mixture of nitric acid and sodium nitrate (/^ 65°C)0 
Accordingly, the non-conjugated 10- and 12-hydroperoxy octadecadien- 
oates obtained by photo-oxidation of cholesteryl linoleate are almost 
certainly the cis.trans isomers analogous to those reported by 
Cobern2-^ et al. and Hall et al,, and would not be expected to 
exhibit stereomutation at room temperature. The stereochemistry of 
the olefinic bonds follows from the proposed mechanism (Fig, M>), 
it is assumed that a cis olefinic bond which has migrated adopts a 
trans configuration.
Photo-sensitised linoleate oxidation should produce equal 
quantities of conjugated and non-conjugated hydroperoxides. In the 
present work, however, GLC of the reduction products indicated an excess 
of the conjugated species, implying that a free radical reaction 
also occurs. It seems likely that the hydroperoxides arising 
via photo-oxygenation may be the initiators of the free
98
n 316radical process*
Both autoxidation and photo-oxidation of cholesteryl linoleate
yielded small quantities of epimeric 7-hydroperoxycholesterol
linoleates, 7-Hydroperoxycholesterols may be readily obtained by
photo-oxygenation of cholesterol, but it has been demonstrated
that polyunsaturated acids esterified with cholesterol give rise to
a higher rate of steroid oxidation than either free cholesterol or
69its saturated or mono-unsaturated esters* An intramolecular
6^  69reaction has been proposed, ' in which a free radical present
on the linoleate moiety of the ester abstracts hydrogen from the
allylic methylene at in the steroid nucleus. Subsequent
attack try oxygen and lydrogen abstraction by the resultant peroxy
radical yields 7-hydroperoxycholesteryl linoleate.
Recently other examples of a similar type of remote intra-
288 289 333molecular oxidation of the steroid nucleus have been described, * *
288
Breslow and co-workers have shown that photolysis of the p-
benzoyl-^-phenyl propionic acid ester of 5otf~cholestan-3o^-ol 
introduces functional groups into the stanol at 2) or
OXYGENATED STEROL ESTERS IN TISSUE
The occurrence of hydroxy sterol esters.
It has now been shown that three distinct, though structurally
similar types of oxygenated sterol esters occur in severely diseased
human aorta. These esters comprise cholesterol esterified with
hydroxy-, bydroperoxy- and keto-octadecadienoic acids, and small
quantities of esterified oxygenated sterols are found associated
with each group. We have demonstrated that similar compounds may
be prepared via cholesteryl linoleate autoxidation.
If these compounds play any pathogenic role in atherosclerosis,
variations in their concentrations throughout various stages of
the disease might be expected. Accordingly a survey was undertaken
to establish whether such a relationship exists. The hydroxy-
esters were chosen as representatives of the oxygenated esters,
since they are the predominant type, and because at the time the
structures of the hydroperoxy- and keto-esters had not beeen fully
determined. Prior to the survey, doubts that the hydroxy-esters
isolated in extracts might arise by oxidation of cholesteryl
linoleate during the extraction and chromatographic procedures were
1 )
dispelled by an experiment in which cholesteryl 1- 0 -linoleate
was added to an extract, and the activity of the isolated hydroxy
esters was determined. It was concluded that not more than 2$o of
the isolated bydroxy-esters could have been derived from cholesteryl
, 5L
linoleate during the course of the experiment.
Aortas collected within 2k hours of death were visually graded 
into three categories: fatty streaks, fibrous atheromas and 
ulcerated plaques. It will be noted (Table ll) that the subjects 
in all groups covered a wide range of age and clinical diagnosis.
In most cases only plaques of a single type were collected from one 
aorta, but Case 9 afforded enough fibrous atheromas and ulcerated
100
plaques to permit measurements on both types. The observed 
differences in concentration of the hydroxy-esters of cholesterol 
in lesions representing different stages in the progression of 
atherosclerosis are quite striking (Table 12), None of these 
compounds was detected in fatty streaks: this indicated that the
concentration was less than 1 yug/g of lipid. In fibrous plaques 
the concentration averaged 89 J*g/gs and in ulcerated plaques this 
rose to 335 g* It is of interest that in Case 9 the hydroxy- 
ester concentration in fibrous plaques was higher than in other 
cases, but still only half those of ulcerated lesions.
The significance of these observations must be speculative.
If ulcerated plaques merely represent atheromas that have been 
developing for a long time, then higher concentrations of these 
compounds might be explained by accumulation over a number of years. 
However, the rate of accumulation would have to be considerably 
greater than those of the major lipid classes, and it may be relevant 
to consider possible processes whereby such relative increases of 
hydroxy-esters could occur, for example:
(1) The hydroxy-esters form a constant proportion of the lipids 
deposited into arterial tissue from blood, but are metabolically 
more inert than the major lipid classes, and hence their relative 
concentrations rise with increased deposition,
(2) The hydroxy-esters in blood increase in parallel with arterial 
degeneration, and are consequently deposited in larger quantities 
in advanced lesions,
(3) The hydroxy-esters are formed gradually in situ. Their higher 
concentrations in advanced lesions may result from higher rates 
of production in severely diseased tissue, or because their rates 
of metabolism are less than those of the other lipid classes,
(4.) The hydroxy-esters are formed episodically as a result of 
thrombosis or other metabolic derangements.
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The present work has not as yet been extended to analysis of 
blood, and we are unable to say whether the hydroxy-esters arise 
by infiltration or are produced by local synthesis. The close 
association of these compounds with cholesteryl linoleate may explain 
why detectable quantities of hydroxy-esters do not occur in fatty 
streaks, since most of the cholesteryl esters in the latter probably 
arise by local synthesis and contain little linoleate.101*102 In 
contrast, advanced lesions contain large quantities of extracellular 
cholesteryl linoleate (presumably derived from blood), which may be 
the substrate for the in situ synthesis of the lydroxy-esters.
4.2* 2. The possible role of hydroperoxides.
Although we can offer no direct evidence, it seems probable
that the hydroperoxy-esters isolated from diseased arteries are
derived from cholesteryl linoleate, and that the hydroperoxides are
in turn the precursors of the hydroxy- and keto-esters. In accordance
with the ease with which the latter compounds may be prepared
chemically from the tydroperoxides, it has been found that methyl
linoleate hydroperoxides administered to rabbits are metabolised
290 291 325
with the formation of esters of byfo’o^y-2103-^*8* 9 9
262 292Christophersen and 0*Brien and Little have demonstrated
that hydroperoxides linoleic acid and methyl linoleate may be
reduced to the corresponding hydroxy compounds by a glutathione
262
peroxidase isolated from rat liver. It has been suggested that
a rapid enzymic reduction of hydroperoxides breaks the catalytic
chain reaction of autoxidation and so protects the vital cellular
compounds from the effect of peroxides.
The origin and significance of hydroperoxides in aortal tissue
293
is a matter of conjecture. Glavind and co-workers demonstrated 
increasing amounts of hydroperoxides with advancing atherosclerosis.
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Subsequent work has indicated that most of the peroxides
observed in arterial tissue after dissection probably occur as
artefacts, but does not exclude the possibility that lipid peroxides
292,
play a role in atherogenesis, Studies on the toxicity of
lipoperoxides suggest that only trace quantities in the tissues
are tolerated, Patty acid hydroperoxides are highly toxic when
295 296administered intraperitoneally, 9 though they appear to be
297,298
less harmful when administered orally. During carbon tetrachloride
299
and yellow phosphorus intoxication experiments in rats, per- 
oxidative decomposition of hepatic microsomal lipid occurs, and may 
be an important step in the abnormal accumulation of fat. Since 
the membrane systems of the cell contain large quantities of poly­
unsaturated fatty acids, lipid peroxidation can obviously have 
detrimental effects. Besides undergoing the autocatalytic reaction
with unsaturated fatty acids, J the highly reactive peroxide may
300,301
react with other intracellular substances such as proteins 
and enzymes, 302,303
Atherogenesis may be enhanced by substances capable of
irritating the arterial wall, and it has been suggested that
irritants may arise by the reaction of molecular oxygen with serum
or arterial lipids.50^ Experiments on animals have shown that
the severity of induced atherosclerosis is increased by feeding of
cupric acetate50*1"*5°^ (a good catalyst for the oxidation of lipids
by molecular oxygen), and decreased by oxidation inhibitors such
305
as ascorbic acid, thiamine, **-tocopherol and thyroxine 
Analyses of serum in patients with and without history of myocardial
infarction has indicated a correlation between heart disease and
, , 306,307
elevated serum copper levels.
In a study of the possible role of peroxides in atherosclerosis, 
Johnson508 concluded that most, if not all, of the peroxides detected 
in atherosclerotic plaques were formed in the interval between
103
death and analysis. It was also indicated that whereas arterial 
tissue obtained during surgery demonstrated peroxides associated 
only with the phospholipids, peroxides of all the major lipid classes 
were present in arterial lesions of tissue obtained at post mortem 
examination. Although the structures of the peroxidised cholesterol 
esters were not elucidated, it seems likely that they are similar 
to those found in the present study. As yet we have been unable to 
detect peroxides of the other lipid classes. However we have 
recently observed that diseased arterial tissue obtained during surgery 
and examined analytically within 12 hr of dissection contains no 
detectable hydroperoxides but substantial quantities of lydroxy-esters. 
It seems probable that hydroperoxides occurring in arterial lesions 
are reduced to the corresponding hydroxy-esters, thereby keeping the 
concentrations of the toxic hydroperoxides at very low levels.
Those isolated from aortas obtained at post mortem examination are 
almost certainly fomed in the interval between death and analysis.
It is tempting to suggest that the mechanism whereby hydroperoxides 
are reduced does not function after death, and that this results in 
their accumulation. However, peroxidation of plaque lipid occurs 
readily in vitro, and some of the isolated hydroperoxides almost 
certainly occur as artefacts between post mortem examination and 
tissue extraction, (See footnote on page 102*.)
2f.2.3* General significance of the present observations.
There is a view of the pathogenesis of atherosclerosis which 
holds that the disease should be considered as a mixture of processes, 
each with distinguishable morphology, natural history and biochemical 
abnormalities.^ The observed differences in concentration of the 
hydroxy-esters may be significant in this context. In particular, 
they indicate what may be an important chemical distinction between 
fatty streaks and plaques.
The toxic properties of peroxides are well established.
Infusion of small quantities of methyl linoleate hydroperoxides
0induces symptoms of vitamin E deficiency in chicks and
311haemolysis in rabbits. Lipid peroxides have also been
. , ♦ a . . 297,298implicated m  ageing, carbon tetrachloride hepatotoxicity
and ionising radiation d a m a g e , a n d  a recent
publication indicates a relationship between peroxide formation 
3 1 3
and inflammation. It is possible that arterial hydroperoxides
or their derivatives may be concerned with the biochemical changes
which result in necrosis, inflammation and ulceration of lesions,
u 31!,
features which distinguish fibrous plaques from fatty streaks.
Recent work indicates that as much as 20$ of the hydroperoxides 
isolated from severely diseased aortas may be formed from 
cholestexyl linoleate during the extraction and chromatographic 
procedures*
CHOLESTANOL AND ATHEROSCLEROSIS
The biological significance of cholestanol is still obscure.
This compound is able to meet or partially replace the requirements
of cholesterol for growth in various insects and micro-organisms,
and cholestanol formation has been shown to occur in a variety of
mammalian tissues. Rat liver homogenates convert 5<*’Cholestan-3—
318
one to cholestanol, and the demonstration that the adrenals,
liver and intestine of germ-free guinea pigs convert cholesterol to
cholestanol rulesout the possibility that this conversion could occur
319solely through intestinal flora. Human subjects are also able
■520to transform cholesterol to cholestanol and human aortic segments 
removed at surgery or post mortem have been shown capable of
268
synthesising cholestanol from acetate or mevalonic acid.
The earlier hypothesis that this sterol could be involved in
the pathogenesis of atherosclerosis was based on the apparent presence
of relatively large concentrations of cholestanol in diseased human 
107 108
aorta. 9 With the development of more sensitive analytical
techniques, the actual concentrations of cholestanol in arteries has
been shown to be much lower. ^  The present study is the first in
which the presence of cholestanol in diseased arterial tissue has
been rigorously proved by combined gas chromatography-mass spectrometry.
The quantities of cholestanol isolated were found to be in the range
0.3-0.3$ of the total sterols in the extracts. A recent paper by
111Fumagalli and co-workers has shown that there is no correlation 
between the aortal concentrations of cholestanol and the degree of 
atherosclerosis. The quantities found add confirmation to our own 
and to previous work. Despite the fact that cholestanol was one of 
four sterols found particularly toxic towards organ cultures of rabbit 
aorta, ^  there seems to be no substantial evidence that this stanol 
plays a significant part in the pathogenesis of atherosclerosis.
DIESTKRS OF 26-HYDROXYCHOLESTEROL 
The cholesterol esters from advanced aortal lesions are 
characteristic in that the major fatty acid to which cholesterol is 
esterified is linoleic acid, which accounts for 35-k5c& of the total
acids esterified with cholesterol and those in diesters of 26- 
hydroxycholesterol has shown that the latter contain a strikingly 
lower proportion of linoleic acid (12 t
It has recently been shown that unesterified 26-hydroxy-
cholesterol occurs both in normal aorta and in aortas representing
111 128
all stages of atherosclerosis. * It was also noted that the
concentration of 26—hydro^ycholesterol appeared to rise in parallel
128
with that of cholesterol, and it has been suggested that the 
accumulation of this minor sterol may be a result of the progression 
of atherosclerosis. The biosynthesis of 26-hydroxycholesterol from
9 7 7  z pp
cholesterol has been demonstrated in liver tissue preparations, ;
The present work has not been extended to investigate the occurrence
of 26-hydrojgycholesterol or its esters in tissue other than aortal
113
intima: however, other investigators have recorded the absence
of detectable quantities of this sterol from human serum and human 
liver tissue.
The cholesterol esters from extracellular lipid of the earliest
lesions contain large quantities of linoleate, and are similar in this
respect to the cholesterol esters of serum lipid. In intracellular
cholesterol esters the major ester is oleate and much smaller quantities
90 101 102
of linoleate are found. * 9 This implies that extracellular
lipid arises largely by infiltration from blood, whereas intracellular 
lipid is of different origin and may perhaps be produced by local
in the present study are predominantly extracellular and the cholesterol 
esters contain the expected large proportions of linoleate. In
esterified acids.100 In the present case, comparison of the fatty
synthesis. Lipids of advanced lesions of the type examined
contrast the major acids represented in the diesters of 26- 
hydroxycholesterol are palmitate and oleate. It is possible, 
therefore, that these diesters are present mainly as intracellular
constituents formed by local synthesis.
111 128The recent surveys 9 in which the aortal concentrations 
of 26-hydroxycholesterol were shown to be correlated with increasing 
severity of atherosclerosis possibly suggests that this sterol 
plays a role in human atherogenesis. The nature of such a role 
will no doubt be the subject of further investigation.
APPENDICES
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APPENDIX I. Chromatographic Data
I
Acid methyl esters 10$EEGA,180°£ I^SE-30,172^ 1$0V-17,172°0
A I eel I eel I eel
MYRISTATE 2085 14.00 1705 14.00 1810 14.00
PAIMITATE 2280 16.00 1910 16.00 2020 16.00
PALMITOLEATE 9 cis 2525 16.45 1880 15.70 2110 16.85
STEARATE 2480 18.00 2115 18.00 2225 18.00
OLEATE 9 ois 2510 18.30 2065 17.50 2225 18.00
LINOLEATE 9,12 
all cis
2570 18.90 20 65 17.50 2230 18.05
LINOELAIDATE 9,12
all trans
2565 18.85 2080 17.65 2240 18.15
LINQLENATE 9,12,15 
all cis
2650 19.70 2065 17.50 2250 18.25
ARACHLDATE 2680 20.00 2320 20.00 2425 20.00
EICOSENOATE 11 cis 2710 20.30 2280 19.60 2A20 19.90
EICOSADIENOATE 11,14 2760 20.90
EICOSATRIENOATE 11,14,17 2850 21.70 2270 19.50 2455 20.20
ARACHIDONATE 5,8,11,14 2840 21.60 2240 19.10 2420 19.90
EEEENATE 2880 22.00 2525 22.00 2630 22.00
LIGNOCERATE 5080 24.00 2730 24.00 2835 24.00
TABLE 17. G-as chromatographio retention data for reference fatty acid 
methyl esters.
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Cholesteryl Ester
Relative Carbon No, 
SE-30, 320°C
Rf
Benzene: Hexane 
(2:1 v/v)
MYRISTATE 14.00 0.69
PALMITATS 16.00 0.70
PAIMITQLEATE 15.95 0.47
STEARATE 18.00 0.68
OLEATE 18.00 0.45
ELAIDATE 17.95 0.57
LINOLEATE 17.80 0.20
LINOELAIDATE 17.75 0.47
L3NGLSNATE 17.80 0.03
ARACHTDATE 20.00 0.69
EICOSATRIENOATE 19.70 0.06
ARACHIDONATE 19.60 0.01
BEHENATE 22.00
ERUCATE 21.70
LIGNOCERATE 24.00
NERVONATE 23.60
14-METHYL HEXADECANOATE 16.95 0.71
TABLE 18. Thin-layer and gas chromatographio retention data for 
reference cholesteryl esters. The TU3 adsorbant was 
Kieselgel G-HR impregnated with 11% (Vw) silver 
nitrate.
I l l
Sterol TMS ether I240°Vfo SE-30
Kf
Benzene: 
Hexane 
(1:2 v/v)
Colour with 
eerie 
sulphate 
reagent
CHOLEST-5-EN-3|3-OL ,3090 0.53 Red
CHOLEST-5-EN-3a-OL 2995 0,66 Red
5a-CHOLESTAN-3a-OL 3020 0.85 Lt. Brown
5a-CHOLESTAN-3(3~OL 3090 0.54 Lt. Brown
5p~CHOLESTAN-3a-OL 3020 0.78 Lt. Brown
5(3-CHOLESTAN-3|3~OL 3015 0.83 Lt. Brown
CHOLEST-5 -ENE-3 (3, 7a-DI0L# 3090 0.55 Blue
CHOLEST-5-ENE-3Pi7P-DIOL * 3220 0.18 Blue
CHOLESTANE-3 (3, 6a-DI0L * 3250 0.33 Brown
CHOLESTANE-3(3,6p-DIOL * 3200
CHOLESTANE-5a,6a-LIOL * 3140 0.65 Brown
CHOLESTANE-5a,6(3-DIOL * 3105
CHOLESTAEE-3(3,5a,6(3-TRIOL * 3340 )
* *  ?225 >
0.10 ) 
0.68 )
Brown
Brown
CHOLES T - 5 -EN -3 (3-OL - 7 -ONE 3220 0 .2 6 Yellow
CHOLEST-5-ENE-3 (3,20a-DI0L * 3275 0.63 Lt, Brown
CHOLEST-5-ENE-3p,24-LIOL * 3360 0.43 Pink-Brown
CHOLEST-5-ENE-3(3 * 25-LIOL # 3390 0 .4 1 Brown
CHOLEST-5-ENE-3p,26-DIOL * 3440 0.31 Pink
TABLE 19. Thin-layer and gas chromatographic data for reference 
sterol TMS ethers.
* his-TMS
* * tris -TMS
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Relevant data for di-n-bufcyl phthalate.
149 C-O-CH
+OH
167
261
PIG-, 47, Mass spectrum of Di-butyl phthalate.
Retention Index 
2820 
2225 
1910
Column 
1Cyfo H3GA ■ 
1 % 07-17 
ss-30
Temperature (°C) 
200 
200 
160
Material tested
Quantity of 
di-n-butyl
nhthalate
Diethyl ether (reagent grade) l6j«.g/l.
Diethyl ether (anhydrous) 70/ig/l,
Diethyl ether (Pronalys) 82>ug/l,
Diethyl ether (anhydrous) redistilled 2 ju.g/l0
Ethyl acetate (AnalaR) 28/tg/l.
Ethyl acetate redistilled n.d.
Ethyl acetate "Nanograde" n.d.
Chloroform (AnalaR) 25yU/g/l,
Chloroform (Nanograde) n.d.
Hexane redistilled n.d.
Hexane Nanograde n.d.
Ethanol Absolute 2^g/l.
Silicic Acid 100 mesh 15/4dj/100g
M N -Kieselgel GHR 10;U.|/l00g
Na pSO^  anhydrous AnalaR 63/isOOOg
TABLE Proportions of di-n-butyl phthalate in solvents and reagents 
used in the present work.
n.d. indicates undetectable quantities of di-butyl phthalate, i.e. 
concentrations of less than 0.1 jx.
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APPENDIX III. The origin of the ion n/ e = 130 in the mass spectra 
of conjugated octadecadienediol bis TMS ethers.
The mass spectra of octadecadienediols bis TMS ethers derived 
from autoxidised cholesteryl linoleate contain an ion of high relative 
abundance at W  e = 130. This ion does not occur in the mass spectra 
of trimethylsilylated octadecanediols or non-conjugated octadecadienediols, 
However, the mass spectra of the latter show an intense ion at n/e = 129 
which has been previously observed in the mass spectra of trimethyl­
silylated hydroxy acid esters derived from autoxidised methyl oleate,
206
and the following mechanism has been proposed.
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Postulated mechanism accounting for the occurrence of the ion 
of c/q = 130 in the mass spectra of conjugated octadecadiene- 
diol bis TMS ethers.
114
In the present work labelling of 9>11-octadecadiene-1,13-diols 
with perdeuterated bis—trimethylsilvl acetamide resulted in an increase 
of m^e = 130 to n/e = 139 in the mass spectra of the resultant TMS 
ethers (Fig. 9)* This indicates the presence in the fragment of an 
intact trimethylsilyloxy group, and requires a molecular formula of 
C3H5OTMS+-. Deuterium labelling of the methylene attached to 
the primary hydroxyl function by reduction of hydroperoxy-esters of 
cholesteryl linoleate with lithium aluminium deuteride, and subsequent 
mass spectral analysis of the TMS ethers gave no rise in the mass 
ef nj/o « 130.
Thus it seems probable that the occurrence of this ion requires a 
system comprising a trimethylsilyloxy function allylic to a pair of 
conjugated olefinic bonds.
Reduction of keto-esters derived from autoxidised cholesteiyl 
linoleate with lithium aluminium deuteride produces octadecadienediols 
with a deuterium atom attached to the or ^ (13) car^on atom holding
the secondary alcohol group. The mass spectra of the TMS ethers of
these compounds (Fig. 18) shows not only an ion at n/e =130 but also 
an ion of almost equal intensity at n/e = 131. In the mass spectra 
of non-labelled 9,11 -octadecadiene-1,13-diol bis TMS ethers ^ _e = 130 
is the base peak, with m/e = 355 having a relative abundance of about 
90$. However, the mass spectra of the labelled derivatives from keto- 
esters have a base peak of n/e = 358, with n/e = 130 having a relative 
abundance of 63^ . If the relative intensities of the ions at = 130 
and 131 are added, then the intensity of i = 358 relative to this sum 
is 83$. The results strongly suggest that incorporation of a deuterium 
atom in the derivatives from keto-esters results in a "splitting" of 
the ion at n/e = 130 in the non-labeiled compound into a pair of ions 
at n/e - 130 and n/j3 =131. A mechanism rationalising these findings
is proposed in Fig. 48.
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